ParkerVision, Inc.
PARKERVISION INC (Form: 10-K, Received: 03/15/2010 16:01:46)
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-K
(Mark One)
 (X)   
ANNUAL REPORT PURSUANT TO SECTION 13 OR
   
15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2009
 
  (  )   
TRANSITION REPORT PURSUANT TO SECTION 13 OR
 
 15(d) OF THE SECURITIES ACT OF 1934
 
For the transition period from          to                
 
Commission file number   0-22904

PARKERVISION, INC.
(Exact Name of Registrant as Specified in Its Charter)

 
Florida
59-2971472
(State of Incorporation)
(I.R.S. Employer ID No.)
 
 
7915 Baymeadows Way, Suite 400
Jacksonville, Florida 32256
(Address of Principal Executive Offices)

Registrant’s telephone number, including area code:   (904) 732-6100

Securities registered pursuant to Section 12(b) of the Act:

 
Title of Each Class
Name of Each Exchange on Which Registered
 
Common Stock, $.01 par value
The Nasdaq Global Market
 
Common Stock Rights
The Nasdaq Global Market

Securities registered pursuant to Section 12(g) of the Act:
None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes (  )  No (X)

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Securities Exchange Act.  Yes (  )  No (X)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d)   of the Securities Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes (X) No (  )

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such file).
Yes (  ) No (  )

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  (X)
 

 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Securities Exchange Act.  (Check one):
 
 
Large accelerated filer (   )
Accelerated filer (X)
 
Non-accelerated filer (   )
Smaller reporting company (  )
 
(Do not check if a smaller reporting company)
 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Securities Exchange Act).   Yes (  ) No (X)

As of June 30, 2009, the aggregate market value of the registrant’s common stock, $.01 par value, held by non-affiliates of the registrant was approximately $90,138,931 (based upon $3.06 share closing price on that date, as reported by The Nasdaq Global Market).

As of March 10, 2010, 41,192,550 shares of the Issuer's Common Stock were outstanding.

2

 
TABLE OF CONTENTS

INTRODUCTORY NOTE
4
     
PART I
   
Item 1.
Business
4
Item 1A.
Risk Factors
8
Item 1B.
Unresolved Staff Comments
11
Item 2.
Properties
11
Item 3.
Legal Proceedings
11
Item 4.
Reserved
  11
     
     
PART II
   
Item 5.
Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
12
Item 6.
Selected Financial Data
13
Item 7.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
14
Item 7A.
Quantitative and Qualitative Disclosures About Market Risk
21
Item 8.
Consolidated Financial Statements and Supplementary Data
22
Item 9.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
44
Item 9A.
Controls and Procedures
44
Item 9B.
Other Information
45
     
PART III
   
Item 10.
Directors, Executive Officers and Corporate Governance
45
Item 11.
Executive Compensation
49
Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
62
Item 13.
Certain Relationships and Related Transactions and Director Independence
64
Item 14.
Principal Accountant Fees and Services
65
     
PART IV
   
Item 15.
Exhibits, Financial Statement Schedule and Reports on Form 8-K
66
     
SIGNATURES
70
     
SCHEDULE
71
     
EXHIBIT INDEX
72
 
3


INTRODUCTORY NOTE

Unless the context otherwise requires, in this Annual Report on Form 10-K (“Annual Report”) “we”, “us”, “our” and the “Company” mean ParkerVision, Inc.

Forward-Looking Statements

We believe that it is important to communicate our future expectations to our shareholders and to the public.  This report contains forward-looking statements, including, in particular, statements about our future plans, objectives, and expectations under the headings “Item 1. Business” and “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this Annual Report.  When used in this Annual Report and in future filings by the Company with the Securities and Exchange Commission (“SEC”), the words or phrases “will likely result”, “management expects”, “we expect”, “will continue”, “is anticipated”, “estimated” or similar expressions are intended to identify “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.  Readers are cautioned not to place undue reliance on such forward-looking statements, each of which speaks only as of the date made.  Such statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results and those presently anticipated or projected. Examples of such risks and uncertainties include the timely development and commercial acceptance of new products and technologies, reliance on key business and sales relationships, and reliance on our intellectual property. We have no obligation to publicly release the results of any revisions which may be made to any forward-looking statements to reflect anticipated events or circumstances occurring after the date of such statements.

PART I

Item 1.  Business.

We were incorporated under the laws of the state of Florida on August 22, 1989.  We are in the business of designing, developing and selling our proprietary radio frequency (“RF”) technologies and products for use in semiconductor circuits for wireless communication products.  Our business is expected to include licensing of our intellectual property and/or the sale of integrated circuits based on our technology for incorporation into wireless devices designed by our customers.  Our business also includes the joint development and marketing of wireless radio modules that incorporate our technologies.  In addition, from time to time, we provide engineering consulting and design services to our customers, for a negotiated fee, to assist them in developing prototypes and/or products incorporating our technologies.

Our business operates under a single segment.  Refer to Item 6 to this Annual Report for select financial data including our net losses from operations and total assets. We are primarily focused on incorporating our technologies into mobile handsets, but our technologies are applicable to other wireless products that are related to networks serving mobile handsets such as data cards, femtocells, machine-to-machine (M2M) and embedded applications.  Our technology can also be applied to non-cellular radio applications such as military radios.

Recent Developments

On November 16, 2009, we closed an offering for the sale of 8,000,000 shares of our common stock under a shelf registration statement for aggregate gross proceeds of $16 million.  Piper Jaffray & Co. (“Piper Jaffray”) acted as the sole underwriter and manager of the offering.  The net proceeds from the offering, after underwriter discounts and commissions and other offering expenses were approximately $14.6 million and will be used for general working capital purposes.

General Development of Business

In 2005, we began educating prospective customers about the benefits of our technologies, with a primary
 
4

 
focus on our RF transmit, or d2p™, technology and its unique ability to address certain high-priority market needs related to mobile handset applications.  In 2006, we completed our first d2p integrated circuit (“IC”) which embodied many of the advancements of our technology and enabled us to begin demonstrating partially-integrated prototypes.  Throughout 2006, 2007 and 2008, we continued to further advance our prototype ICs and increased the level of prototype integration while cultivating potential customer relationships.  Our sales-related activities during this period included prototype demonstrations of our d2p platform, support of in-depth technical due-diligence by prospective customers, analysis of prospective customer product requirements, delivery of initial proposals and terms, and ultimately, negotiations of proposed business relationships.   We currently have three customers for our technology.

ITT Corporation (“ITT”) entered into both a licensing and an engineering services agreement with us in 2007.   During 2007, ITT engaged us under the engineering services agreement to analyze and evaluate the architectural design alternatives for incorporation of our technology into RF circuits based on various product specifications provided by ITT.   In addition, in 2008, we delivered a development/demonstration platform to ITT for their use in product development and demonstration to their customers.  In late 2008 and early 2009, ITT marketed our technology, based on our commercial designs, to a number of their customers and in October 2009, ITT was awarded a government contract for the demonstration of our technology in a highly integrated transceiver application for military products.  ITT in turn, engaged us as a subcontractor to incorporate our commercial ICs into an existing highly integrated transceiver platform.  The services related to this product demonstration are expected to be completed in the first quarter of 2010.  Under our licensing agreement with ITT, we will collect a royalty on a per unit basis for any products sold by them that incorporate our technology.

Late in 2007, we also entered into a licensing and engineering services agreement with a global baseband chipset supplier whose name remains confidential under the terms of our agreement with them (“Confidential Licensee”).  During 2008, our product development efforts were largely focused on advancing our ICs from prototype to production-ready samples for this and other potential customers.  We delivered production-ready d2p silicon samples that met or exceeded all critical functional and performance requirements under our agreement to our Confidential Licensee late in 2008.  During 2009, we worked with our Confidential Licensee and other vendors on further refining our d2p silicon samples for specific mobile phone standards and on developing various packaging designs and production test programs.  We also worked with our customer to co-develop sample 3G mobile handsets for the purpose of verifying the technology in a working implementation, testing the technology in actual network operation and creating sales samples for our Confidential Licensee. In October 2009, our customer tested and accepted delivery of the initial sample handsets.  We are currently working with our customer to market this product to their customers and to set up the manufacturing arrangements for volume production.  Under the terms of our licensing agreement this customer has the right to manufacture devices based on the licensed technology for a royalty on a per unit basis or we may sell such devices directly to third parties.

In December 2008, we entered into a Product and Market Development Agreement (the “LGI Agreement”) with LG Innotek Co., Ltd. (“LGI”), a division of the LG Group.  The agreement provides for a cooperative working relationship between us and LGI for the development and marketing of RF modules that incorporate our technologies for use in mobile applications such as wireless handsets and data cards.  The agreement provides for a supplier relationship between us and LGI whereby we would sell LGI tested, unpackaged integrated circuits for incorporation into modules.  The agreement initially contemplates modules designed for commercial HEDGE applications.   HEDGE is an acronym for applications that incorporate support for 2G, 2.5G and 3G waveform standards including GSM, EDGE, WCDMA, and HSPA.   During 2009, we worked closely with LGI on both product development and joint marketing activities.  We are also exploring applications for modules that more closely align with the 3G offering of our Confidential Licensee in order to generate more near-term revenue opportunities for LGI, our Confidential Licensee and us.

To date, we have generated no royalty or product revenue from our d2p technology.  Our ability to generate revenues sufficient to offset costs is subject to our ability to successfully support our customers in completing their initial product designs and our ability to secure a reasonable market share through product offerings with our current customers and/or the addition of new customers and/or products.     We believe our technology
 
5

 
has substantial advantages over competing technologies, especially in the third generation, or 3G, mobile handset market and generations that are evolving beyond 3G, such as 4G mobile handset standards and applications.

Technology and Products

Our wireless technologies represent unique, proprietary methods for processing RF waveforms in wireless applications.  The technology applies to the transmit (baseband data to RF carrier signal) and receive (RF carrier signal to baseband data) functions of a radio transceiver.  The transmit portion of the technology is called Direct2Power™, or d2p, and enables the transformation of a baseband data signal to an RF carrier waveform, at the desired power output level, in a single unified operation.  The receiver portion of the technology is called Direct2Data™, or d2d™, and enables the direct conversion of an RF carrier to a baseband data signal.  Although our primary sales efforts were focused on commercialization of our d2p technology solutions, both of the agreements with customers in the commercial handset market contemplate future incorporation of our d2d technology as well.

We have completed engineering prototypes of our d2p-based ICs targeted at certain mobile handset applications.  The ICs which incorporate the core RF technology were produced using a Silicon Germanium (“SiGe”) process through a fabrication relationship with IBM Microelectronics (“IBM”).   Late in 2008, we completed the integration of the digital engine that controls our RF transmit IC and interfaces to the mobile phone baseband processor.  This digital engine was produced through a third-party fabrication relationship using a Taiwan Semiconductor Manufacturing Company Limited (“TSMC”) CMOS semiconductor process.  These ICs are utilized to verify that our technology can be highly integrated in silicon and to demonstrate the benefits of the technology to target customers.

Our current prototypes support functionality that is multi-band (meaning multiple frequencies) and multi-mode (meaning multiple cellular standards and corresponding modulation formats). Our ICs support multiple bands of cellular and PCS (Personal Communications Service) frequencies and support the current and emerging cellular standards including GSM/EDGE, CDMA, W-CDMA, and HSUPA.  We are also able to demonstrate 802.16e WiMax and LTE standards with our current ICs, although we utilize the cellular and PCS frequencies for such demonstrations.

Our unique technologies process the RF waveform in a more optimal manner than traditional technologies, thereby allowing the creation of handsets that have extended battery life, more easily incorporate multiple air interface standards and frequencies in smaller form factors, and reduce manufacturing costs.   Our technologies provide such attractive benefits, in part, because of their unique integrated circuit architecture which enables creation of highly accurate RF waveforms that use less power than traditional linear transmitter architectures and components thereby extending battery life, reducing heat and enabling certain packaging advantages.

Marketing and Sales

When we targeted the cellular industry in 2005, our initial target customer base was focused on the top tier mobile handset manufacturers.  However, in 2006 and 2007, mobile handset manufacturers were shifting RF innovation and developments to their chipset providers.  Accordingly, we expanded our target customer base to include not only the mobile handset manufacturers, but also their component suppliers.   Our Confidential Licensee and LGI are both component suppliers to mobile handset OEMs (Original Equipment Manufacturers) and/or ODMs (Original Design Manufacturers).

Although our primary target market is the mobile handset industry, we have also explored potential relationships outside this target market to the extent that the requirements of the prospective customers are in concert with the needs of our primary target market.   This exploration resulted in our licensing agreement with ITT.
 
6


Our marketing and sales activities are currently focused on developing and capitalizing on relationships in the mobile handset industry.   Although we believe our direct customers will likely be the chipset suppliers in this industry, we continue to cultivate our relationships with the mobile handset manufacturers who, at a minimum, exert major influence on their chipset suppliers.  In addition, our market awareness campaign includes network providers who exert significant influence on the OEMs in the mobile handset industry.

Our sales and sales support activities include prototype demonstrations of both semi-integrated and highly-integrated circuits that showcase the benefits of our technology, support of detailed technology due-diligence discussions and testing, analysis of potential customer product roadmaps and integration alternatives, negotiations of specific terms of potential business relationships, and both technical and sales support of customers during their design process.

We believe the sales cycle, from the initial customer meeting to the consummation of a business arrangement, can vary from six to twenty-four months.  The length of the sales cycle is a result of many factors, including the unique nature of our technology, our lack of tenure in the cellular industry, the variety of integration decisions that must be evaluated by the customer in order to assess the specific value proposition for their needs, and the intense technology evaluation and due-diligence required by target customers.  The intense technology evaluation and due-diligence efforts are a result of the complex nature of RF technology, the complexity of the cellular specifications, and the unit volumes contemplated.  We believe the average sales cycle will shorten significantly as our technologies gain adoption in this market.

We executed our first two customer contracts in 2007 and an additional customer arrangement in 2008.  Our current sales and marketing focus is on assisting our customers to achieve design wins and to obtain orders from their customers.  We believe that the rate of adoption of our technology will increase as shipments of products incorporating our technologies commence.  Future sales may be influenced by the terms negotiated with our customers and our ability to expand internal resources to support multiple customers.

Competition

We operate in a highly competitive industry against companies with substantially greater financial, technical, and sales and marketing resources.   Our technologies, which are currently being marketed in the mobile handset industry, face competition from incumbent providers of transceivers and power amplifiers including companies such as Anadigics, Infineon, Freescale, Qualcomm, RF Microdevices, Skyworks, and ST Ericsson, among others.   Each of our competitors, however, also has the potential of becoming a customer for our technologies.   We may also compete against RF engineering groups within the research and development organizations of our target customers, although we do not have such competition today within the confines of our existing three customers.  To date, we are unaware of any competing or emerging RF technologies that provide all the simultaneous benefits that our technology enables.

Hurdles to the adoption of our technologies include entrenchment of existing technologies, the disruptive nature of our technology, and our lack of tenure in the markets we are targeting.  We believe we can gain adoption, and therefore compete, based on the performance and cost advantages enabled by our unique circuit architecture, as supported by a solid and defensible intellectual property (“IP”) portfolio.  Our circuit architecture is capable of being compliant with all current mobile phone standards and can be configured to accept all standard baseband data inputs.  In addition, we believe that one or more of our technology’s abilities to provide improved power efficiencies, highly accurate RF carrier waveforms, smaller form factors and better manufacturing yields, provides a solution to existing problems in applications for 3G standards and beyond that the mobile handset industry is seeking to solve.
 
Production and Supply

Our current business strategy is focused largely on the incorporation of our technology into mobile handsets and data devices that operate on wide area mobile networks.  In instances where our customer is a licensee of
 
7

 
our IP, the production capacity risk shifts to that customer.   Under our agreement with LGI, we will be supplying unpackaged, tested ICs.  Those ICs will be produced for us under various foundry relationships.  We currently have a fabrication relationship with IBM for the production of our prototype ICs on a SiGe process.  We have also produced ICs through TSMC using a CMOS semiconductor process.  We believe IBM and TSMC have sufficient capacity to meet our foreseeable needs.  In addition, our ICs can be produced using different materials and processes, if necessary, to satisfy capacity requirements and/or customer preferences.

Patents and Trademarks

We consider our IP, including patents, patent applications, trademarks, and trade secrets to be significant to our competitive positioning.   We have a program to file applications for and obtain patents, copyrights, and trademarks in the United States and in selected foreign countries where we believe filing for such protection is appropriate to establish and maintain our proprietary rights in our technology and products.  We currently have obtained 94 U.S. and 59 foreign patents related to our RF technologies.  In addition, we have approximately 54 U.S. and 25 foreign patent applications pending.  We estimate the economic lives of our patents to be fifteen to twenty years.

In addition, from time to time, we obtain licenses from others for standard industry circuit designs that are integrated into our own ICs as supporting components that are peripheral to our core technologies.  We believe there are multiple sources for these types of standard circuits and we estimate the economic lives of the licenses to be two to five years based on estimated technological obsolescence.

Research and Development

For the years ended December 31, 2009, 2008 and 2007, we spent approximately $13.5 million, $14.6 million, and $10.7 million, respectively, on company-sponsored research and development activities.  Our research and development efforts have been, and are expected to continue to be, devoted to the development and advancement of RF technologies, including the development of prototype ICs for proof of concept purposes and production-ready silicon samples and reference designs for our customers.

Employees

As of December 31, 2009, we had 51 full-time employees, of which 31 are employed in engineering research and development, 8 in sales and marketing, and 12 in executive management, finance and administration.  Our employees are not represented by a labor union.  We consider our employee relations satisfactory.

Available Information and Access to Reports

We file annual reports on Forms 10-K, quarterly reports on Forms 10-Q, proxy statements and other reports, including any amendments thereto, electronically with the SEC.  The SEC maintains an Internet site ( http://www.sec.gov ) where these reports may be obtained at no charge. Copies of these reports may also be obtained from the SEC’s Public Reference Room at 100 F Street, NE, Washington, DC  20549.  Information on the operation of the SEC Public Reference Room may be obtained by calling the SEC at 1-800-SEC-0330.  Copies of these reports may also be obtained at no charge from the Company’s website (http://www.parkervision.com) via the link “SEC filings”.  We also will provide copies of the annual report on Form 10-K and the quarterly reports on Forms 10-Q filed during the current fiscal year, including any amendments thereto, upon written request to us at ParkerVision, Inc, Investor Relations, 7915 Baymeadows Way, Suite 400, Jacksonville, Florida, 32256.  These reports will be provided at no charge.  Exhibits to these reports may be obtained at a cost of $.25 per page plus $5.00 postage and handling.

Item 1A.  Risk Factors.

In addition to other risks and uncertainties described in this Annual Report, the following risk factors should be carefully considered in evaluating our business because such factors may have a significant impact on our
 
8

 
business, operating results, liquidity and financial condition.  As a result of the risk factors set forth below, actual results could differ materially from those projected in any forward-looking statements.

We have had a history of losses which may ultimately compromise our ability to implement our business plan and continue in operation.
We have had losses in each year since our inception in 1989, and continue to have an accumulated deficit which, at December 31, 2009, was approximately $212 million.  The net loss for 2009 was approximately $21.5 million.  To date, our technologies and products have not produced revenues sufficient to cover operating, research and development and overhead costs.  We also will continue to make expenditures on marketing, research and development, pursuit of patent protection for our intellectual property and operational costs for fulfillment of any contracts that we achieve for the sale of our products or technologies.  We expect that our revenues in 2010 will not bring the company to profitability.  If we are not able to generate sufficient revenues or we have insufficient capital resources, we will not be able to implement our business plan and investors will suffer a loss in their investment.  This may result in a change in our business strategies.

We expect to need additional capital in the future, which if we are unable to raise will result in our not being able to implement our business plan as currently formulated.
Because we have had net losses and, to date, have not generated positive cash flow from operations, we have funded our operating losses from the sale of equity securities from time to time and the sale of our video division in 2004.  We anticipate that our business plan will continue to require significant expenditures for research and development, patent protection, sales and marketing and general operations.  Our current capital resources, including cash and cash equivalents at December 31, 2009 of $13.5 million are expected to sustain operations through 2010 .   Thereafter, unless we increase revenues to a level that covers operating expenses or we reduce costs, we will require additional capital to fund these expenses.  Financing, if any, may be in the form of loans or additional sales of equity securities. A loan or the sale of preferred stock may result in the imposition of operational limitations and other covenants and payment obligations, any of which may be burdensome to us. The sale of equity securities will result in dilution to the current shareholders’ ownership.  The long-term continuation of our business plan is dependent upon the generation of sufficient revenues from the sale of our products, additional funding, reducing expenses or a combination of the foregoing.  The failure to generate sufficient revenues, raise capital or reduce expenses could have a material adverse effect on our ability to achieve our long-term business objectives.

Our industry is subject to rapid technological changes which if we are unable to match or surpass, will result in a loss of competitive advantage and market opportunity.
Because of the rapid technological development that regularly occurs in the microelectronics industry, we must continually devote substantial resources to developing and improving our technology and introducing new product offerings.  For example, in fiscal years 2009 and 2008, we spent approximately $13.5 million and $14.6 million, respectively, on research and development, and we expect to continue to spend a significant amount in this area in the future. These efforts and expenditures are necessary to establish and increase market share and, ultimately, to grow revenues. If another company offers better products or our product development lags, a competitive position or market window opportunity may be lost, and therefore our revenues or revenue potential may be adversely affected.

If our products are not commercially accepted, our developmental investment will be lost and our ability to do business will be impaired.
There can be no assurance that our research and development will produce commercially viable technologies and products.  If existing or new technologies and products are not commercially accepted, the funds expended will not be recoverable, and our competitive and financial position will be adversely affected. In addition, perception of our business prospects will be impaired with an adverse impact on our ability to do business and to attract capital and employees.

If our patents and intellectual property do not provide us with the anticipated market protections and competitive position, our business and prospects will be impaired.
We rely on our intellectual property, including patents and patent applications, to provide competitive advantage and protect us from theft of our intellectual property.  We believe that many of our patents are for
 
9

 
entirely new technologies.  If the patents are not issued or issued patents are later shown not to be as broad as currently believed, or are otherwise challenged such that some or all of the protection is lost, we will suffer adverse effects from the loss of competitive advantage and our ability to offer unique products and technologies.  As a result, there would be an adverse impact on our financial condition and business prospects.

If we cannot demonstrate that our technologies and products can compete in the marketplace and are better than current competitive solutions, then we will not be able to generate the sales we need to continue our business and our prospects will be impaired.
We expect to face competition from chip suppliers such as Anadigics, Infineon, Freescale, Qualcomm, RF Microdevices, Skyworks, and ST Ericsson, among others.  Our technology may also face competition from other emerging approaches or new technological advances which are under development and have not yet emerged.  If our technologies and products are not established in the market place as improvements over current, traditional chip solutions in wireless communications, our business prospects and financial condition will be adversely affected.

We rely, in large part, on key business and sales relationships for the successful commercialization of our products, which if not developed or maintained, will have an adverse impact on achieving market awareness and acceptance and will result in a loss of business opportunity.
To achieve a wide market awareness and acceptance of our products, as part of our business strategy, we will attempt to enter into a variety of business relationships with other companies which will incorporate our technologies into their products and/or market products based on our technologies.  The successful commercialization of our products will depend in part on our ability to meet obligations under contracts with respect to the products and related development requirements.  The failure of these business relationships will limit the commercialization of our products which will have an adverse impact on our business development and our ability to generate revenues and recover development expenses.

We rely, in large part, on the ability of key customers to successfully develop and sell products incorporating our technologies, the failure of which will have an adverse impact on our business opportunities.
The successful commercialization of our products will depend, in part, on the success and timing of our customers’ product development and sales activities which may be impacted by factors outside of our control.  Delays in or failure of our customers’ product development or sales activities will hinder the commercialization of our products which will have an adverse impact on our ability to generate revenues and recover development expenses.

We are highly dependent on Mr. Jeffrey Parker as our chief executive officer.  If his services were lost, it would have an adverse impact on our leadership and on how we are perceived within the industry and by investors.
Because of Mr. Parker’s position in the company and the respect he has garnered in both the industry in which we operate and the investment community, the loss of his services might be seen as an impediment to the execution of our business plan.  If Mr. Parker were no longer available to the company, investors might experience an adverse impact on their investment.  We currently have an employment agreement with Mr. Parker and we maintain key-employee life insurance for our benefit on Mr. Parker.

If we are unable to attract or retain key executives and other highly skilled employees, we will not be able to execute our current business plans.
Our business is very specialized, and therefore it is dependent on having skilled and specialized key executives and other employees to conduct our research, development and customer support activities.  The inability to obtain or retain these key executives and other specialized employees would have an adverse impact on the research, development and technical customer support activities that our products require.  These activities are instrumental to the successful execution of our business plan.
 
10


Our outstanding options and warrants may affect the market price and liquidity of the common stock.
At December 31, 2009, we had 41,160,335 shares of common stock outstanding and had 5,628,723 exercisable options and warrants for the purchase of shares of common stock, assuming no terminations or forfeitures of such options and warrants.  On December 31, 2010 and 2011, respectively, there will be 5,873,454 and 5,958,242 currently exercisable options and warrants (assuming no new grants, exercises, terminations or forfeitures since December 31, 2009).   All of the underlying common stock of these securities is registered for sale to the holder or for public resale by the holder.  The amount of common stock available for the sales may have an adverse impact on our ability to raise capital and may affect the price and liquidity of the common stock in the public market.  In addition, the issuance of these shares of common stock will have a dilutive effect on current shareholders’ ownership.

Provisions in the certificate of incorporation and by-laws could have effects that conflict with the interest of shareholders.
Some provisions in our certificate of incorporation and by-laws could make it more difficult for a third party to acquire control of us.  For example, the board of directors has the ability to issue preferred stock without shareholder approval, and there are pre-notification provisions for director nominations and submissions of proposals from shareholders to a vote by all the shareholders under the by-laws.  Florida law also has anti-takeover provisions in its corporate statute.

We have a shareholder protection rights plan that may delay or discourage someone from making an offer to purchase the company without prior consultation with the board of directors and management which may conflict with the interests of some of the shareholders.
On November 17, 2005, the board of directors adopted a shareholder protection rights plan which called for the issuance, on November 29, 2005, as a dividend, of rights to acquire fractional shares of preferred stock.  The rights are attached to the shares of common stock and transfer with them.  In the future the rights may become exchangeable for shares of preferred stock with various provisions that may discourage a takeover bid.  Additionally, the rights have what are known as “flip-in” and “flip-over” provisions that could make any acquisition of the company more costly.  The principal objective of the plan is to cause someone interested in acquiring the company to negotiate with the board of directors rather than launch an unsolicited bid.  This plan may limit, prevent, or discourage a takeover offer that some shareholders may find more advantageous than a negotiated transaction.  A negotiated transaction may not be in the best interests of the shareholders.

Item 1B.  Unresolved Staff Comments.

None.

Item 2. Properties.

Our headquarters are located in a 14,000 square foot leased facility in Jacksonville, Florida.  We have an additional leased facility in Lake Mary, Florida primarily for engineering design activities.   We believe our properties are in good condition and suitable for the conduct of our business.  Refer to “Lease Commitments” in Note 11 to the Consolidated Financial Statements included in Item 8 for information regarding our outstanding lease obligations.

Item 3. Legal Proceedings.

We are subject to legal proceedings and claims arising in the ordinary course of business.  Based upon the advice of outside legal counsel, we believe that the final disposition of such matters will not have a material adverse effect on our financial position, results of operations or liquidity.

Item 4.  Reserved.
 
11


PART II

Item 5. Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Market Information

Our common stock is traded under the symbol PRKR   on The Nasdaq Global Market ("Nasdaq"), which is the principal market for the common stock.  Listed below is the range of the high and low sale prices of the common stock for the last two fiscal years, as reported by Nasdaq.

   
2009
   
2008
 
   
High
   
Low
   
High
   
Low
 
Quarter ended March 31
  $ 3.22     $ 1.55     $ 16.12     $ 4.80  
Quarter ended June 30
    4.00       1.68       12.35       7.40  
Quarter ended September 30
    4.90       2.55       13.69       8.35  
Quarter ended December 31
    4.10       1.41       10.99       2.00  

Holders

As of February 12, 2010, we had 133 holders of record and we believe there are approximately 3,000 beneficial holders of our common stock.

Dividends

To date, we have not paid any dividends on our common stock.  The payment of dividends in the future is at the discretion of the board of directors and will depend upon our ability to generate earnings, our capital requirements and financial condition, and other relevant factors.  We do not intend to declare any dividends in the foreseeable future, but instead intend to retain all earnings, if any, for use in the business.

Sales of Unregistered Securities

None.

Issuer Repurchase of Equity Securities

None.

Performance Graph

The following graph shows a five-year comparison of cumulative total shareholder returns for our company, the Nasdaq U.S. Stock Market Index, the Nasdaq Electronic Components Index and Nasdaq Telecommunications Index for the five years ending December 31, 2009.  The total shareholder returns assumes the investment on December 31, 2004 of $100 in our common stock, the Nasdaq U.S. Stock Market Index, the Nasdaq Electronic Components Index, and Nasdaq Telecommunications Index at the beginning of the period, with immediate reinvestment of all dividends.
 
12

 
COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN*
Among ParkerVision, Inc., The NASDAQ Composite Index,
The NASDAQ Telecommunications Index And The NASDAQ Electronic Components Index
*$100 invested on 12/31/04 in stock or index, including reinvestment of dividends.
Fiscal year ending December 31.
 
The data points for the performance graph are as follows:
 
   
12/04
12/05
12/06
12/07
12/08
12/09
               
ParkerVision, Inc.
 
100.00
102.25
125.28
177.75
27.75
20.56
NASDAQ Composite
 
100.00
101.33
114.01
123.71
73.11
105.61
NASDAQ Telecommunications
 
100.00
91.66
119.67
132.55
77.09
107.17
NASDAQ Electronic Components
 
100.00
107.81
101.44
116.92
59.73
97.30
 
Item 6.  Selected Financial Data.

The following table sets forth our consolidated financial data as of the dates and for the periods indicated.  The data has been derived from our audited consolidated financial statements.  The selected financial data should be read in conjunction with our consolidated financial statements and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
 
13

 
   
For the years ended December 31,
 
(in thousands, except per share amounts)
 
2009
   
2008
   
2007
   
2006
   
2005
 
Consolidated Statement of Operations Data:
                             
                               
Revenues, net
  $ 64     $ 0     $ 284     $ 0     $ 996  
Gross margin
    10       0       32       0       (2,041 )
Operating expenses
    21,559       23,432       19,122       16,866       21,362  
Total interest and other income
    20       358       876       1,051       304  
Net loss from continuing operations
    (21,530 )     (23,074 )     (18,213 )     (15,816     (23,099 )
                                         
Basic and diluted net loss per common share from continuing operations
    (0.65 )     (0.88 )     (0.74 )     (0.68 )     (1.14 )
                                         
Consolidated Balance Sheet Data:
                                       
Total assets
  $ 25,545     $ 17,976     $ 26,577     $ 26,675     $ 23,832  
Long term obligations
    155       238       344       433       5  
Shareholders’ equity
    23,883       16,110       24,414       25,183       22,400  
Working capital
    12,577       4,043       12,611       13,313       10,833  
 
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations.

Executive Overview

We are in the business of designing, developing and selling our proprietary RF technologies and devices for use in semiconductor circuits for wireless communication products.  We currently have three customer contracts for the incorporation of our technologies into wireless chipsets, modules and products. Two of the three customer agreements represent licensing arrangements whereby our customers will incorporate our IP into their own wireless semiconductor circuits and/or radio products. We also have engineering services agreements in place with these two customers whereby we will provide engineering services on a time and materials basis as requested by our customers.  The third contract represents a joint development and marketing agreement for the development of RF modules for incorporation into wireless products.  This agreement contemplates, upon completion of development, the negotiation of a supply agreement whereby we would supply our technology in the form of tested, unpackaged integrated circuits, also referred to as “known good die” or “KGD”, for incorporation into complete modules by our customer.

The two licensing customers include ITT and the Confidential Licensee.  The Confidential Licensee is a fabless supplier of chipsets that support 2G, 2.5G and 3G mobile standards with engineering design and sales locations in both North America and Asia.  The Confidential Licensee designs and supplies chipsets, and related handset reference designs, predominantly to handset OEMs and ODMs for incorporation into mobile handsets.  Our joint development and marketing agreement is with LGI for the development of wireless radio modules for mobile handset and data card applications.

Since exiting our wireless retail product business in 2005, we have generated no product or royalty revenue from our wireless RF technologies.  We have recognized service revenue in 2007 and 2009 resulting from engineering design services provided to ITT.   We anticipate initial royalty and/or product revenue from one or more of these customer arrangements to commence in 2010.

Our ability to generate revenues sufficient to offset costs is subject to our ability to successfully support our customers in completing their initial product designs incorporating our technologies and expand our market opportunities through additional product offerings with our current customers and/or the addition of new customers.

We believe our technology has substantial advantages over competing technologies, especially in the 3G mobile handset market and generations that are likely to evolve beyond 3G, such as 4G mobile handset standards and applications.   We have made significant investments in developing our technologies and
 
14

 
products, the returns on which are dependent upon the generation of future revenues for realization.   Since we have not yet generated revenues sufficient to offset our operating expenses, we have mostly relied on proceeds from the sale of equity securities to fund our operations.  We intend to continue to use our working capital to support future marketing, sales, research and development and general operations.

Critical Accounting Policies

We believe that the following are the critical accounting policies affecting the preparation of our consolidated financial statements:

Intangible Assets

Patents, copyrights and other intangible assets are amortized using the straight-line method over their estimated period of benefit.  We estimate the economic lives of our patents and copyrights to be fifteen to twenty years.  We estimate the economic lives of other intangible assets, including licenses, based on estimated technological obsolescence, to be two to five years, which is generally shorter than the contractual lives.   Periodically, we evaluate the recoverability of our intangible assets and take into account events or circumstances that may warrant revised estimates of useful lives or that indicate impairment may exist (“Triggering Event”).  Based on our cumulative net losses and negative cash flows from operations to date, we assess our working capital needs on an annual basis.  This annual assessment of our working capital is considered to be a Triggering Event for purposes of evaluating the recoverability of our intangible assets.  As a result of our evaluation, and the significant excess of our market capitalization over our net book value at December 31, 2009, we determined that no impairment exists with regard to our intangible assets.

Accounting for Share-Based Compensation

We calculate the fair value of share-based equity awards, including restricted stock, stock options and restricted stock units (“RSUs”), on the date of grant and recognize the calculated fair value, net of estimated forfeitures, as compensation expense over the requisite service periods of the related awards. The fair value of share-based awards is determined using various valuation models which require the use of highly subjective assumptions and estimates including (i) how long employees will retain their stock options before exercising them, (ii) the volatility of our common stock price over the expected life of the equity award, and (iii) the rate at which equity awards will be ultimately be forfeited by the recipients.  Changes in these subjective assumptions can materially affect the estimate of fair value of share-based compensation and consequently, the related amount recognized as expense in the consolidated statements of operations.

Revenue Recognition

We did not recognize any product or royalty revenue in 2009, 2008 or 2007.

We account for service revenue when there is persuasive evidence of an arrangement, services have been rendered, the fee is fixed or determinable, and collection of the resulting receivable is reasonably assured.
 
We use the percentage-of-completion method of accounting for cost reimbursement-type contracts which specify a certain billable fee amount.  Revenues are recognized as costs are incurred assuming that collection is reasonably assured.  Our cost of sales includes the direct labor costs of personnel providing services under these contracts, as well as indirect costs such as depreciation, amortization and allocated facilities costs.
 
Income Taxes

The provision for income taxes is based on loss before taxes as reported in the accompanying consolidated statements of operations.  Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been included in the financial statements or tax returns. Deferred tax assets and liabilities are determined based on differences between the financial statement carrying amounts and the tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are
 
15

 
expected to reverse.  Valuation allowances are established to reduce deferred tax assets when, based on available objective evidence, it is more likely than not that the benefit of such assets will not be realized.

On January 1, 2007 we adopted the provisions for the accounting for uncertainty in income taxes.  This standard prescribes a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.  This standard also provides guidance on recognition and classification of income tax assets and liabilities, accounting for interest and penalties associated with tax positions, accounting for income taxes in interim periods and income tax disclosures.   

Recent Accounting Pronouncements

On September 30, 2009, we adopted the new Accounting Standards Codification (“ASC”) as issued by the Financial Accounting Standards Board (“FASB”). The ASC has become the source of authoritative U.S. GAAP recognized by the FASB to be applied by nongovernmental entities. The ASC is not intended to change or alter existing GAAP. The adoption of the ASC did not have a material impact on our consolidated financial statements. Unless needed to clarify a point to readers, we will refrain from citing specific section references when discussing application of accounting principles or addressing new or pending accounting rule changes.

On June 30, 2009, we adopted the FASB guidance for subsequent events which requires public entities to evaluate subsequent events through the date that the financial statements are issued.

On January 1, 2009, we adopted the FASB guidance related to fair value measurements for nonfinancial assets and liabilities. Adoption of this guidance did not have an effect on our operating income or net earnings.

On January 1, 2009, we adopted the FASB guidance for the determination of the useful life of intangible assets which amends the factors that should be considered in developing the renewal or extension assumptions used to determine the useful life of a recognized intangible asset. The new guidance also requires expanded disclosure regarding the determination of intangible asset useful lives. Adoption of this guidance did not have an impact on our consolidated financial statements.

On January 1, 2009, we adopted the FASB guidance on determining whether instruments granted in share-based payment transactions are participating securities. This guidance requires companies to treat unvested share-based payment awards that have non-forfeitable rights to dividends or dividend equivalents as participating securities when computing earnings per share, pursuant to the two-class method. Our awards do not have non-forfeitable rights to dividends or dividend equivalents and, therefore, the adoption of this guidance did not have any impact on our financial statements.
 
Results of Operations for Each of the Years Ended December 31, 2009, 2008 and 2007

Revenues and Gross Margins

We had no product or royalty revenues for the years ended December 31, 2009, 2008 or 2007.

In October 2009, we were engaged by ITT under a fixed-price service contract to incorporate our d2p commercial integrated circuits into a highly integrated transceiver for purposes of demonstrating the performance of the device to one of ITT’s military customers.  The service contract is valued at approximately $130,000.  For the year ended December 31, 2009, we recognized $64,000 in service revenue and approximately $10,000, or 15% in gross margin related to this contract.  We recorded an additional $51,000 billed under this contract to deferred revenue at December 31, 2009.  We expect to recognize the remaining revenue under this contract in the first quarter of 2010.

For the year ended December 31, 2007, we recognized approximately $284,000 in service revenue and
 
16

 
approximately $32,000, or 11%, in gross margin related to engineering consulting services provided to ITT.   These services included analysis and evaluation of architectural design alternatives for incorporation of our d2p technology into RF circuits based on various product specifications provided by ITT.

Cost of sales for engineering services includes the direct labor costs, as well as overhead and other indirect costs including depreciation, amortization and allocated facilities costs.   Indirect costs are allocated to cost of sales on a direct labor hour basis.

We anticipate initial royalty and/or product revenue from one or more of our customer arrangements to commence in 2010.

Research and Development Expenses

Research and development expenses decreased by approximately $1.1 million, or 7.6%, from 2008 to 2009.   This decrease was primarily due to decreases in outside engineering design and consulting fees and software development tools and related maintenance costs.  Our personnel costs, including wages, taxes, benefits, recruitment and travel costs, also decreased from 2008 to 2009, however these decreases were offset by increases in share-based compensation expense.  We also experienced an increase in amortization costs related to our patents and licenses.

Outside engineering design services are utilized to supplement our internal engineering resources and the related fees are generally project-based and vary based on the magnitude and timing of those projects.  Overall, these fees decreased from 2008 to 2009 by approximately $940,000 as a result of the completion of certain development programs late in 2008, offset by new programs initiated in the second half of 2009 which were largely focused on the HEDGE development project.   Software support and related maintenance costs decreased by approximately $265,000 from 2008 to 2009 as a result of re-negotiation of fees with various software providers as part of our cost-reduction measures implemented in late 2008 as well as changes in the software tools necessary to support our product designs.

Research and development personnel expenses, excluding share-based compensation, decreased approximately $240,000 from 2008 to 2009.  This is primarily due to a decrease in cash incentive payments to employees, reduced travel expenses, and a reduction in recruiting costs.  This decrease was offset by an increase of $270,000 in our share-based compensation expense for the same period.  The increase in share-based compensation expense is a result of new equity awards to non-executive employees to offset the impact of the reduced cash incentive programs, as well as the continued attribution of expense for engineering executive and other employee RSU awards made in 2008.

Our patent and license amortization cost increased from 2008 to 2009 by approximately $180,000 due to continued additions to our patent portfolio and the purchase of licenses in 2008 and 2009 related to our product development activities.

Our research and development expenses increased approximately $3.9 million, or 36.6%, from 2007 to 2008.  This increase was primarily due to increases in personnel costs, including employee share-based compensation expense, outside engineering design and consulting fees, prototype production costs, and software development tools and related maintenance costs.

From 2007 to 2008, our charges for outside design services increased approximately $1,710,000.  These increases were a result of projects that were largely completed by the end of 2008.  Software maintenance and support costs for engineering design software increased approximately $230,000 from 2007 to 2008 due to additional software tools and related maintenance costs required for IC design work.

From 2007 to 2008, research and development personnel and related costs, excluding share-based compensation expense, increased approximately $580,000 as a result of compensation increases for existing engineering staff, the addition of personnel, and increased travel expense, offset by decreases in cash incentive bonuses from 2007 to 2008.  Employee share-based compensation increased by approximately
 
17

 
$995,000 from 2007 to 2008, primarily due to the noncash expense related to restricted shares and RSUs issued to engineering executives and other employees in 2008 as long-term incentive compensation and in lieu of cash incentive bonuses.

Prototype IC production costs increased approximately $305,000 from 2007 to 2008 largely due to the addition of a second foundry, TSMC, for prototype runs.  We maintain a fairly regular cycle of prototype chip runs; however, the fabrication costs may vary from period to period based on the materials specified and the number of variants requested on each run.

The markets for our products and technologies are characterized by rapidly changing technology, evolving industry standards and frequent new product introductions.  Our ability to successfully develop and introduce, on a timely basis, new and enhanced products and technologies will be a significant factor in our ability to grow and remain competitive.  Although we anticipate decreases in our research and development expenses in 2010, particularly with regard to outside design services, we are committed to continue investing in our technology and product development and therefore we anticipate that we will use a substantial portion of our working capital for research and development activities in 2010.

Marketing and Selling Expenses

Marketing and selling expenses decreased by approximately $0.5 million, or 19.3%, from 2008 to 2009.  This decrease is primarily due to decreases in outside professional services and personnel and related expenses, partially offset by an increase in share based compensation.

Outside professional services include various consulting and legal fees related to sales and marketing activities.  These fees decreased from 2008 to 2009 by approximately $360,000 as a result of a reduction in public relations and other technical marketing services rendered, coupled with a re-negotiation of fees early in 2009 with certain sales consultants.

Marketing and sales personnel costs, excluding share-based compensation, decreased from 2008 to 2009 by approximately $165,000, primarily as a result of reduced employee head count, the elimination of cash incentive programs, and reduced travel expenses.  This was somewhat offset by an increase in share-based compensation expense of approximately $35,000 for the same period as a result of new equity awards made to employees in 2009 to offset the impact of the elimination of the cash incentive program as well as the continued attribution of expense related to equity awards made in 2008.

Marketing and selling expenses decreased by approximately $0.1 million or 3.7%, from 2007 to 2008.  This decrease was primarily due to decreases in personnel and related costs and non-employee share-based compensation, partially offset by an increase in employee share-based compensation expense and outside professional services.

Marketing and sales personnel costs, excluding share-based compensation, decreased from 2007 to 2008 by approximately $160,000, primarily due to a reduction in employee cash bonuses, partially offset by increases in sales and marketing employee travel costs.   Non-employee share-based compensation decreased approximately $135,000 from 2007 to 2008 primarily as a result of the reversal of previously recognized compensation expense on performance-based options which expired unvested in 2008.  These decreases were partially offset by increases in employee share-based compensation expense of approximately $205,000 primarily due to the noncash expense related to RSUs issued to sales and marketing executives and other employees in 2008 as long-term incentive compensation.  In addition, fees for outside professional services increased from 2007 to 2008 by approximately $65,000.

We are committed to continuing our investment in marketing and selling efforts in order to continue to increase market awareness and penetration of our products and technologies.

18


General and Administrative Expenses

General and administrative expenses consist primarily of executive, finance and administrative personnel costs and costs incurred for insurance, shareholder relations and outside professional services.  Our general and administrative expenses decreased by approximately $0.3 million, or 4.1%, from 2008 to 2009.  This decrease is due primarily to decreases in cash fees to outside directors along with decreases in corporate travel costs, outside professional fees, and insurance costs.  These decreases were partially offset by increases in share-based compensation expense.

Our outside director cash compensation decreased approximately $250,000 from 2008 to 2009 as a result of non-employee directors waiving their cash director fees in favor of equity compensation for 2009.  This decrease in directors’ cash fees was offset by an increase in share-based compensation of approximately $445,000 from 2008 to 2009.  The increase in share-based compensation is a result of approximately $325,000 in share-based compensation expense related to the value of nonqualified stock options issued to our non-employee directors as payment for director and committee fees in 2009.  In addition, we granted an aggregate of 150,000 share options to two outside consultants resulting in an increase in non-employee share-based compensation of approximately $155,000.

Our outside professional fees decreased by approximately $140,000 from 2008 to 2009 due to a reduction in outside legal services incurred for the period.  In addition, the cost of our directors’ and officers’ liability insurance decreased by approximately $35,000 from 2008 to 2009 due to general market conditions. Our corporate travel costs decreased approximately $110,000 from 2008 to 2009 due to specific measures taken to reduce costs, including the sale of a fractional ownership in an aircraft in January 2009.

Our general and administrative expenses increased by approximately $0.5 million, or 8.6%, from 2007 to 2008.  This increase was primarily due to increases in share-based compensation expense partially offset by decreases in other personnel and related costs, insurance and corporate travel costs.

Share-based compensation expense increased approximately $825,000 from 2007 to 2008, largely due to RSUs issued to named executives and other employees in 2008 as long-term incentive compensation.    Our other personnel costs decreased approximately $140,000 from 2007 to 2008 primarily due to a reduction in cash incentive payments to named executives and other employees.  In addition, our corporate travel costs decreased approximately $75,000 from 2007 to 2008 and the cost of our directors’ and officers’ liability insurance decreased by approximately $85,000 from 2007 to 2008 due to general market conditions.

Interest and Other Income

Interest and other income consist of interest earned on our investments, net gains recognized on the sale of investments, and other miscellaneous income. Interest and other income decreased approximately $0.3 million from 2008 to 2009 and approximately $0.5 million from 2007 to 2008.  These decreases are primarily the result of declining interest rates due to market conditions and more conservative investments, as well as lower average cash balances during the respective periods.

Interest Expense

Interest expense represents interest incurred on capital lease obligations as well as interest incurred in connection with a state property tax filing in 2009.

Loss and Loss per Common Share

Our net loss decreased approximately $1.5 million, or $0.23 per share, from 2008 to 2009.  This decrease is primarily a result of a $1.9 million, or 8%, reduction in operating expenses along with a 25% increase in weighted shares outstanding for the period.
 
19


Our net loss increased by approximately $4.9 million, or $0.14 per share, from 2007 to 2008.  This increase is primarily due to a $4.3 million or 22.5% increase in operating expenses, primarily related to research and development activities, offset by a 7% increase in weighted average shares outstanding for the period.

Liquidity and Capital Resources

At December 31, 2009, we had working capital of approximately $12.6 million, which included $13.5 million in cash and cash equivalents.  This represents an increase of approximately $8.6 million over working capital of $4.0 million at December 31, 2008.  The increase in working capital is a result of approximately $24.3 million in proceeds from the sale of equity securities in 2009, less $14.8 million used for operations and $1.0 million used as payment for patents, licenses and fixed assets used in the business during 2009.  Our use of cash in 2009 was offset by $0.2 million proceeds from the sale of property and equipment.  At December 31, 2009, we were not subject to any significant commitments to make additional capital expenditures.

For the year ended December 31, 2008, we used cash of approximately $17.1 for operations and $1.8 million as payments for patent costs, licenses and fixed assets used in operations.  This cash usage was partially offset by $8.9 million in proceeds from the March 2008 sale of equity securities and approximately $1.3 million in proceeds received from the exercise of options and warrants in 2008.

For the year ended December 31, 2007, we received approximately $8.4 million in proceeds from the sale of equity securities and approximately $6.7 million in proceeds from the exercise of approximately 800,000 options and warrants.  These proceeds were offset by the use of approximately $13.5 million in cash for operating activities and approximately $1.4 million for the purchase of property and equipment and for payment of patent costs in 2007.

Our future business plans call for continued investment in sales, marketing, customer support and product development for our technologies and products.  Our ability to generate revenues sufficient to offset costs is subject to our ability to successfully support our customers in completing their initial product designs incorporating our technologies and our ability to secure a reasonable share of the market through additional product offerings with our current customers and/or the addition of new customers.  We expect that revenue for 2010 will not be sufficient to cover our operational expenses for 2010, and that our expected continued losses and use of cash will be funded from available working capital.  We assessed our short-term liquidity needs based on the assumption that our working capital must be sufficient to cover our operational expenses for 2010 with an assumption of minimal revenue.  
 
We expect our overall operating costs in 2010 will be less than those incurred in 2009 as a result of the elimination and/or deferral of certain expenditures related to product development activities and other cost-reduction measures implemented by us.  We believe our current capital resources and our 2010 cost reduction efforts will be sufficient to support our liquidity requirements through 2010.  In the event that sufficient working capital is not available to meet our 2010 liquidity needs, we believe additional liquidity could be obtained through the surrender of key-man life insurance policies for their cash value and/or additional cost reduction measures.  In addition, we may be able to meet future liquidity needs through the issuance of equity securities under our outstanding shelf registration statements or through short or long-term debt financing, although there can be no assurance that such financing will be available to us.  We currently have no significant long-term debt obligations.
 
The long-term continuation of our business plan through 2010 and beyond is dependent upon the generation of sufficient revenues from our technologies and products to offset expenses.  In the event that we do not generate sufficient revenues, we will be required to obtain additional funding through public or private financing and/or further reduce operating costs.  Failure to generate sufficient revenues, raise additional capital through debt or equity financings, and/or further reduce operating costs could have a material adverse effect on our ability to meet our long-term liquidity needs and achieve our intended long-term business objectives.
20


Off-Balance Sheet Transactions, Arrangements and Other Relationships; Contractual Obligations

As of December 31, 2009, we have outstanding warrants to purchase 2,190,139 shares of common stock that were issued in connection with the sale of equity securities in various private placement transactions in 2000, 2001, 2005, 2006 and 2009.  These warrants have exercise prices ranging from $1.88 to $56.66 per share with a weighted average exercise price of $32.16 and a weighted average remaining contractual life of approximately 2 years.  The estimated fair value of these warrants at their date of issuance of $17,767,663 is included in shareholders’ equity in our consolidated balance sheets.  During the year ended December 31, 2009, warrants to purchase 20,000 shares of common stock were exercised at a weighted average exercise price of $1.88, resulting in proceeds of $37,500.  Refer to “Non Plan Options/Warrants” in Note 8 to the consolidated financial statements included in Item 8 for information regarding the outstanding warrants.

Our contractual obligations and commercial commitments at December 31, 2009 were as follows (see “Lease Commitments” in Note 11 to the consolidated financial statements included in Item 8):

 
Payments due by period
Contractual Obligations:
 
Total
   
1 year
 or less
   
2-3
 Years
   
4 - 5
 years
   
After 5
 years
 
Capital leases
  $ 60,000     $ 23,000     $ 37,000     $ 0     $ 0  
Operating leases
    833,000       582,000       251,000       0       0  
 
Item 7A.  Quantitative and Qualitative Disclosures about Market Risk.

Market risk is the risk of loss arising from adverse changes in market and economic conditions and is directly influenced by the volatility and liquidity in the markets in which an asset trades.  Our cash equivalents which are primarily comprised of highly liquid money market instruments are subject to interest rate risk.  We are averse to principal loss and seek to ensure the safety and preservation of our invested funds by limiting market risk.
 
21


Item 8. Consolidated Financial Statements and Supplementary Data.

Index to Consolidated Financial Statements
 
 
Page
   
REPORT OF INDEPENDENT REGISTERED CERTIFIED PUBLIC ACCOUNTING FIRM
23
   
CONSOLIDATED FINANCIAL STATEMENTS:
 
   
Consolidated Balance Sheets - December 31, 2009 and 2008
24
   
Consolidated Statements of Operations - for the years ended December 31, 2009, 2008 and 2007
25
   
Consolidated Statements of Shareholders’ Equity - for the years ended December 31, 2009, 2008 and 2007
26
   
Consolidated Statements of Cash Flows - for the years ended December 31, 2009, 2008 and 2007
27
   
Notes to Consolidated Financial Statements - December 31, 2009, 2008 and 2007
28
   
FINANCIAL STATEMENT SCHEDULE:
 
   
Schedule II – Valuation and Qualifying Accounts
71
   
Schedules other than those listed have been omitted since they are either not required, not applicable or the information is otherwise included.
 
 
22

 
Report of Independent Registered Certified Public Accounting Firm

To the Board of Directors and Shareholders of ParkerVision, Inc.:

In our opinion, the consolidated financial statements listed in the accompanying index   present fairly, in all material respects, the financial position of ParkerVision, Inc. and its subsidiary   at December 31, 2009 and December 31, 2008, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2009   in conformity with accounting principles generally accepted in the United States of America.  In addition, in our opinion, the financial statement schedule listed in the accompanying index presents fairly, in all material respects, the information set forth therein when read in conjunction with the related consolidated   financial statements.  Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2009, based on criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).  The Company's management is responsible for these financial statements and financial statement schedule, for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in Management's Annual Report on Internal Control over Financial Reporting appearing under Item 9A.  Our responsibility is to express opinions on these financial statements, on the financial statement schedule, and on the Company's internal control over financial reporting based on our integrated audits.  We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States).  Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement and whether effective internal control over financial reporting was maintained in all material respects.  Our audits of the financial statements included examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation.  Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk.  Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

As discussed in Note 7 to the consolidated financial statements, the Company changed the manner in which it accounts for uncertain tax positions in 2007.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.  A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
 
Jacksonville, Florida
March 15, 2010
 
23

 
PARKERVISION, INC. AND SUBSIDIARY

CONSOLIDATED BALANCE SHEETS

DECEMBER 31, 2009 AND 2008

   
2009
   
2008
 
CURRENT ASSETS:
           
  Cash and cash equivalents
  $ 13,490,612     $ 4,814,659  
  Accounts receivable
    101,305       0  
  Prepaid expenses and other
    493,157       855,253  
          Total current assets
    14,085,074       5,669,912  
                 
PROPERTY AND EQUIPMENT, net
    835,963       1,376,582  
                 
INTANGIBLE ASSETS, net
    10,078,439       10,398,521  
                 
OTHER ASSETS
    545,945       530,884  
          Total assets
  $ 25,545,421     $ 17,975,899  
                 
CURRENT LIABILITIES:
               
  Accounts payable
  $ 264,059     $ 811,381  
   Accrued expenses:                
        Salaries and wages
    269,630       265,117  
        Professional fees
    749,864       277,422  
        Other accrued expenses
    60,014       168,847  
  Deferred rent, current portion
    113,282       104,458  
  Deferred revenue
    50,733       0  
          Total current liabilities
    1,507,582       1,627,225  
                 
LONG TERM LIABILITIES
               
     Capital lease, net of current portion
    37,495       0  
     Deferred rent, net of current portion
    117,038       238,470  
          Total long term liabilities
    154,533       238,470  
          Total liabilities
    1,662,115       1,865,695  
                 
COMMITMENTS AND CONTINGENCIES  (Notes 8, 9 and 11)
               
                 
SHAREHOLDERS' EQUITY:
               
   Common stock, $.01 par value, 100,000,000 shares  authorized, 41,160,335 and 26,716,080 shares issued and outstanding at December 31, 2009 and 2008, respectively
        411,603           267,161  
   Warrants outstanding
    17,767,663       17,335,777  
   Additional paid-in capital
    217,919,771       189,193,386  
   Accumulated deficit
    (212,215,731 )     (190,686,120 )
          Total shareholders' equity
    23,883,306       16,110,204  
          Total liabilities and shareholders' equity
  $ 25,545,421     $ 17,975,899  
                 
 
The accompanying notes are an integral part of these consolidated financial statements.
 
24

 
PARKERVISION, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF OPERATIONS

FOR THE YEARS ENDED DECEMBER 31, 2009, 2008 AND 2007

   
2009
   
2008
   
2007
 
                   
Engineering services revenue
  $ 64,412     $ 0     $ 283,675  
Cost of sales
    54,440       0       251,314  
   Gross margin
    9,972       0       32,361  
                         
Research and development expenses
    13,504,799       14,618,903       10,700,181  
Marketing and selling expenses
    2,092,148       2,594,010       2,692,887  
General and administrative expenses
    5,962,309       6,219,188       5,729,136  
    Total operating expenses
    21,559,256       23,432,101       19,122,204  
                         
Interest and other income
    36,085       358,204       876,421  
Interest expense
    (16,412 )     0       0  
    Total interest and other income
    19,673       358,204       876,421  
                         
Net loss
  $ (21,529,611 )   $ (23,073,897 )   $ (18,213,422 )
                         
Basic and diluted net loss per common share
  $ (0.65 )   $ (0.88 )   $ (0.74 )
                         
 
The accompanying notes are an integral part of these consolidated financial statements.
 
25

 
PARKERVISION, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

FOR THE YEARS ENDED DECEMBER 31, 2009, 2008 AND 2007
 
   
2009
   
2008
   
2007
 
Common shares – beginning of year
    26,716,080       25,182,892       23,387,566  
     Issuance of common stock upon exercise of options  and warrants
    20,000       185,143       802,885  
     Issuance of common stock in public and private  offerings
    14,244,963       1,240,199       992,441  
     Share-based compensation
    179,292       107,846       0  
Common shares – end of year
    41,160,335       26,716,080       25,182,892  
                         
Par value of common stock – beginning of year
  $ 267,161     $ 251,829     $ 233,876  
     Issuance of common stock upon exercise of options and warrants
    200       1,852       8,029  
     Issuance of common stock in public and private  offerings
    142,449       12,402       9,924  
     Share-based compensation
    1,793       1,078       0  
Par value of common stock – end of year
  $ 411,603     $ 267,161     $ 251,829  
                         
Warrants outstanding – beginning of year
  $ 17,335,777     $ 17,492,097     $ 20,290,878  
     Exercise of warrants
    (21,000 )     (156,320 )     (2,798,781 )
     Issuance of warrants in connection with public  offering
    452,886       0       0  
Warrants outstanding – end of year
  $ 17,767,663     $ 17,335,777     $ 17,492,097  
                         
Additional paid-in capital – beginning of year
  $ 189,193,386     $ 174,282,736     $ 154,056,663  
     Issuance of common stock upon exercise of options  and warrants
    58,300       1,561,857       9,534,984  
     Issuance of common stock in public and private offerings
    23,676,222       8,921,299       8,390,324  
     Share-based compensation
    4,991,863       4,427,494       2,300,765  
Additional paid-in capital – end of year
  $ 217,919,771     $ 189,193,386     $ 174,282,736  
                         
Accumulated deficit – beginning of year
  $ (190,686,120 )   $ (167,612,223 )   $ (149,398,801 )
     Net loss
    (21,529,611 )     (23,073,897 )     (18,213,422 )
Accumulated deficit – end of year
  $ (212,215,731 )   $ (190,686,120 )   $ (167,612,223 )
                         
Total shareholders’ equity – beginning of year
  $ 16,110,204     $ 24,414,439     $ 25,182,616  
     Issuance of common stock upon exercise of options and warrants
    37,500       1,407,389       6,744,232  
     Issuance of common stock and warrants in private and public offerings
    24,271,557       8,933,701       8,400,248  
     Share-based compensation
    4,993,656       4,428,572       2,300,765  
     Net loss
    (21,529,611 )     (23,073,897 )     (18,213,422 )
Total shareholders’ equity – end of year
  $ 23,883,306     $ 16,110,204     $ 24,414,439  
                         

The accompanying notes are an integral part of these consolidated financial statements.
 
26

 
PARKERVISION, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE YEARS ENDED DECEMBER 31, 2009, 2008 and 2007

   
2009
   
2008
   
2007
 
CASH FLOWS FROM OPERATING ACTIVITIES:
                 
  Net loss
  $ (21,529,611 )   $ (23,073,897 )   $ (18,213,422 )
  Adjustments to reconcile net loss to net cash used in  operating activities:
                       
      Depreciation and amortization
    1,741,199       1,620,550       1,649,014  
      Share-based compensation
    4,993,656       4,243,494       2,327,522  
      Impairment loss on asset held for sale
    0       30,700       0  
      (Gain) loss on sale of equipment and other assets
    (1,332 )     24,756       17,860  
      Changes in operating assets and liabilities:
                       
Accounts receivable
    (101,305 )     0       0  
Prepaid and other assets
    347,035       115,986       8,212  
Accounts payable and accrued expenses
    (201,851 )     43,093       750,663  
Deferred rent
    (112,608 )     (96,710 )     (81,276 )
Deferred revenue
    50,733       0       0  
                Total adjustments
    6,715,527       5,981,869       4,671,995  
Net cash used in operating activities
    (14,814,084 )     (17,092,028 )     (13,541,427 )
                         
CASH FLOWS FROM INVESTING ACTIVITIES:
                       
   Purchase of property and equipment
    (74,878 )     (141,521 )     (469,916 )
   Purchase of licenses
    (100,000 )     (694,000 )     0  
   Payment for patent costs
    (818,369 )     (941,986 )     (957,833 )
   Proceeds from sale of property and equipment
    185,977       0       0  
 Net cash used in investing activities
    (807,270 )     (1,777,507 )     (1,427,749 )
                         
CASH FLOWS FROM FINANCING ACTIVITIES:
                       
   Net proceeds from issuance of common stock in  public and private offerings
    24,271,557       8,933,701       8,400,248  
   Proceeds from exercise of options and warrants
    37,500       1,349,661       6,744,232  
   Principal payments on capital lease obligation
    (11,750 )     0       0  
Net cash provided by financing activities
    24,297,307       10,283,362       15,144,480  
                         
NET CHANGE IN CASH AND CASH EQUIVALENTS
    8,675,953       (8,586,173 )     175,304  
                         
CASH AND CASH EQUIVALENTS, beginning of year
    4,814,659       13,400,832       13,225,528  
                         
CASH AND CASH EQUIVALENTS, end of year
  $ 13,490,612     $ 4,814,659     $ 13,400,832  
                         
 
The accompanying notes are an integral part of these consolidated financial statements.
 
27


PARKERVISION, INC. AND SUBSIDIARY

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2009, 2008 and 2007

1.  THE COMPANY AND NATURE OF BUSINESS

We were incorporated under the laws of the state of Florida on August 22, 1989 and currently operate in a single segment - wireless technologies and products.

We are in the business of designing, developing and selling our proprietary radio frequency (“RF”) technologies and products for use in semiconductor circuits for wireless communication products.  Our business is expected to include licensing of our intellectual property and/or the sale of integrated circuits based on our technology for incorporation into wireless devices designed by our customers.  Our business also includes the joint development and marketing of wireless radio modules that incorporate our technologies.  In addition, from time to time, we provide engineering consulting and design services to our customers, for a negotiated fee, to assist them in developing prototypes and/or products incorporating our technologies.

2.   LIQUIDITY AND CAPITAL RESOURCES

We operate in a highly competitive industry with rapidly changing and evolving technologies.  Many of our potential competitors have substantially greater financial, technical and other resources.  We have made significant investments in developing our technologies and products, the returns on which are dependent upon the generation of future revenues for realization.

We have incurred losses from operations and negative cash flows in every year since inception and have utilized the proceeds from the sale of our equity securities to fund our operations.   For the year ended December 31, 2009, we incurred a net loss of approximately $21.5 million and negative cash flows from operations of approximately $14.8 million.  At December 31, 2009, we had an accumulated deficit of approximately $212.2 million and working capital of approximately $12.6 million.

We expect that revenue for 2010 will not be sufficient to cover our operational expenses for 2010, and that our expected continued losses and use of cash will be funded from available working capital.  We assessed our short-term liquidity needs based on the assumption that our working capital must be sufficient to cover our operational expenses for 2010 with an assumption of minimal revenue.
 
We expect our overall operating costs in 2010 will be less than those incurred in 2009 as a result of the elimination and/or deferral of certain expenditures related to product development activities and other cost-reduction measures implemented by us.  We believe our current capital resources and our 2010 cost reduction efforts will be sufficient to support our liquidity requirements through 2010.  In the event that sufficient working capital is not available to meet our 2010 liquidity needs, we believe additional liquidity could be obtained through the surrender of key-man life insurance policies for their cash value and/or additional cost reduction measures.  In addition, we may be able to meet future liquidity needs through the issuance of equity securities under our outstanding shelf registration statements or through short or long-term debt financing, although there can be no assurance that such financing will be available to us.  We currently have no significant long-term debt obligations.
 
The long-term continuation of our business plan through 2010 and beyond is dependent upon the generation of sufficient revenues from our technologies and products to offset expenses.  In the event that we do not generate sufficient revenues, we will be required to obtain additional funding through public or private financing and/or further reduce operating costs.  Failure to generate sufficient revenues, raise additional capital through debt or equity financings, and/or further reduce operating costs could have a material adverse
 
28

 
effect on our ability to meet our long-term liquidity needs and achieve our intended long-term business objectives.
 
3.   SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Consolidation
We formed a wholly owned subsidiary, D2D, LLC on October 2, 2000.  The consolidated financial statements include the accounts of ParkerVision, Inc. and D2D, LLC, after elimination of all significant inter-company transactions and balances.

Basis of Presentation
Our financial statements are prepared in accordance with generally accepted accounting principles.   Certain reclassifications have been made to the 2008 and 2007 consolidated financial statements in order to conform to the 2009 presentation.

Use of Estimates in the Preparation of Financial Statements
The preparation of financial statements in conformity with generally accepted accounting principles requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. The more significant estimates made by us include the volatility, forfeiture rate and estimated lives of share-based awards used in the estimate of the fair market value of share-based compensation, the assessment of recoverability of long-lived assets, the amortization periods for intangible and long-lived assets, and the valuation allowance for deferred taxes.   Actual results could differ from the estimates made.  We periodically evaluate estimates used in the preparation of the consolidated financial statements for continued reasonableness.  Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation.

Cash and Cash Equivalents
We consider cash and cash equivalents to include cash on hand, interest-bearing deposits, overnight repurchase agreements and investments with original maturities of three months or less when purchased.  Our financial assets at December 31, 2009 consist of money market securities, which are included in cash and cash equivalents in the accompanying balance sheets (see note 14).
 
Property and Equipment
Property and equipment are stated at cost, less accumulated depreciation. Depreciation is determined using the straight-line method over the following estimated useful lives:

Manufacturing and office equipment
 
5-7 years
Leasehold improvements
 
Remaining life of lease
Aircraft
 
20 years
Furniture and fixtures
 
7 years
Computer equipment and software
 
3-5 years

The cost and accumulated depreciation of assets sold or retired are removed from their respective accounts, and any resulting net gain or loss is recognized in the accompanying consolidated statements of operations.  The carrying value of long-lived assets is reviewed on a regular basis for the existence of facts, both internally and externally, that may suggest impairment. Recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset.  If the carrying amount of the assets exceeds its estimated undiscounted future net cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the assets.

Long-lived assets to be sold are classified as held for sale in the period in which there is an approved plan for sale of the assets within one year, and it is unlikely that the plan will be withdrawn or changed.  Long-lived
 
29

 
assets held for sale are recorded at the lower of their carrying amount or fair value less estimated costs to sell.

Intangible Assets
Patents, copyrights and other intangible assets are amortized using the straight-line method over their estimated period of benefit.  We estimate the economic lives of our patents and copyrights to be fifteen to twenty years.  We estimate the economic lives of other intangible assets, including licenses, based on estimated technological obsolescence, to be two to five years, which is generally shorter than the contractual lives.   Management evaluates the recoverability of intangible assets periodically and takes into account events or circumstances that may warrant revised estimates of useful lives or that may indicate impairment exists.

Accounting for Share-Based Compensation
We have various share-based compensation programs, which provide for equity awards including stock options and restricted stock. We calculate the fair value of share-based equity awards on the date of grant and recognize the calculated fair value, net of estimated forfeitures, as compensation expense over the requisite service periods of the related awards.  We estimate the fair value of each equity award on the date of grant using the Black-Scholes option valuation model or the Monte Carlo simulation fair value model for awards that contain market conditions.  These valuation models require the use of highly subjective assumptions and estimates including (i) how long employees will retain their stock options before exercising them, (ii) the volatility of our common stock price over the expected life of the equity award, and (iii) the rate at which equity awards will be ultimately be forfeited by the recipients.  Such estimates, and the basis for our conclusions regarding such estimates, are outlined in detail in Note 8.  Estimates of fair value are not intended to predict actual future events or the value ultimately realized by persons who receive equity awards.

We elected to adopt the alternative short cut method for determining the beginning balance of the additional paid-in-capital pool (“APIC pool”) related to the tax effects of employee share-based compensation and to determine the subsequent impact on the APIC pool and consolidated statements of cash flows for the income tax effects of employee share-based compensation awards that were outstanding upon the adoption of ASC 718.

Revenue Recognition
We did not recognize any product or royalty revenue in 2009, 2008 or 2007.

We account for service revenue using the percentage-of-completion method of accounting for cost reimbursement-type contracts which specify a certain billable fee amount.  Revenues are recognized as costs are incurred assuming that collection is reasonably assured.  Our cost of sales includes the direct labor costs of engineering staff providing services under these contracts, as well as indirect costs including depreciation and allocated facilities costs.

Research and Development Expenses
Research and development costs are expensed as incurred and include salaries and benefits, costs paid to third party contractors, prototype expenses, maintenance costs for software development tools, depreciation, amortization, and an allocated portion of facilities costs.

Loss per Common Share
Basic loss per common share is determined based on the weighted-average number of common shares outstanding during each year.  Diluted loss per common share is the same as basic loss per common share as all potential common shares are excluded from the calculation, as their effect is anti-dilutive.  The weighted-average number of common shares outstanding for the years ended December 31, 2009, 2008 and 2007, was 32,963,816, 26,341,213, and 24,620,727, respectively. Options and warrants to purchase 6,019,121, 5,620,339, and 6,631,255 shares of common stock that were outstanding at December 31, 2009, 2008 and 2007 respectively, were excluded from the computation of diluted earnings per share as the effect of these options and warrants would have been anti-dilutive.

Leases
Our facilities are leased under operating leases.  For those leases that contain rent escalations or rent
 
30

 
concessions, we record the total rent payable during the lease term on a straight-line basis over the term of the lease with the difference between the rents paid and the straight-line rent recorded as a deferred rent liability in the accompanying consolidated balance sheets.

Consolidated Statements of Cash Flows
In July 2009, we purchased office equipment under a capital lease and recorded a corresponding capital lease obligation of approximately $72,000.  The lease has a three-year term with monthly payments of approximately $2,400.  The principal payments are reflected as cash outflows from financing activities in the accompanying statements of cash flows.

From time to time, we have issued equity awards in the form of options, RSUs, and restricted stock awards as compensation to our employees, outside consultants and non-executive directors  (see Note 8).

In connection with one of the offerings of shares of our common stock on March 3, 2009, we issued warrants to purchase 431,320 shares of common stock (see Note 9).  These warrants were recorded at their relative fair value of approximately $453,000.

We maintain key-man life insurance policies on two of our named executive officers.  In 2009, policy premiums, totaling an aggregate of approximately $46,000, were paid through the use of the annual policy dividends and a loan against the cash surrender value of one policy for approximately $9,000.   The cash surrender value of these policies as determined by the insurance carrier is approximately $524,000 and is recognized in our other assets on our balance sheet.

Income Taxes
The provision for income taxes is based on loss before taxes as reported in the accompanying consolidated statements of operations.  Deferred tax assets and liabilities are recognized for the expected future tax consequences of events that have been included in the financial statements or tax returns. Deferred tax assets and liabilities are determined based on differences between the financial statement carrying amounts and the tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.  Valuation allowances are established to reduce deferred tax assets when, based on available objective evidence, it is more likely than not that the benefit of such assets will not be realized.

On January 1, 2007 we adopted the provisions for the accounting for uncertainty in income taxes.  This standard prescribes a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.  This interpretation also provides guidance on recognition and classification of income tax assets and liabilities, accounting for interest and penalties associated with tax positions, accounting for income taxes in interim periods and income tax disclosures.   

Recent Accounting Pronouncements

On September 30, 2009, we adopted the new Accounting Standards Codification (“ASC”) as issued by the Financial Accounting Standards Board (“FASB”).  The ASC has become the source of authoritative U.S. GAAP recognized by the FASB to be applied by nongovernmental entities. The ASC is not intended to change or alter existing GAAP. The adoption of the ASC did not have a material impact on our consolidated financial statements. Unless needed to clarify a point to readers, we will refrain from citing specific section references when discussing application of accounting principles or addressing new or pending accounting rule changes.

On June 30, 2009, we adopted the FASB guidance for subsequent events which requires public entities to evaluate subsequent events through the date that the financial statements are issued.

On January 1, 2009, we adopted the FASB guidance related to fair value measurements for nonfinancial assets and liabilities. Adoption of this guidance did not have an effect on our operating income or net earnings.
 
31


On January 1, 2009, we adopted the FASB guidance for the determination of the useful life of intangible assets which amends the factors that should be considered in developing the renewal or extension assumptions used to determine the useful life of a recognized intangible asset. The new guidance also requires expanded disclosure regarding the determination of intangible asset useful lives. Adoption of this guidance did not have an impact on our consolidated financial statements.

On January 1, 2009, we adopted the FASB guidance on determining whether instruments granted in share-based payment transactions are participating securities. This guidance requires companies to treat unvested share-based payment awards that have non-forfeitable rights to dividends or dividend equivalents as participating securities when computing earnings per share, pursuant to the two-class method. Our awards do not have non-forfeitable rights to dividends or dividend equivalents and, therefore, the adoption of this guidance did not have any impact on our financial statements.

4.   PREPAID EXPENSES AND OTHER

Prepaid expenses and other assets consisted of the following at December 31, 2009 and 2008:

   
2009
   
2008
 
Prepaid insurance
  $ 363,036     $ 425,771  
Other prepaid expenses
    126,109       424,020  
Other current assets
    4,012       5,462  
    $ 493,157     $ 855,253  
                 

5.   PROPERTY AND EQUIPMENT, NET

Property and equipment, at cost, consisted of the following at December 31, 2009 and 2008:

   
2009
   
2008
 
Equipment and software
  $ 8,506,363     $ 8,697,497  
Leasehold improvements
    779,343       779,343  
Aircraft (held for sale)
    0       200,550  
Furniture and fixtures
    494,561       494,561  
      9,780,267       10,171,951  
Less accumulated depreciation and  amortization
    (8,944,304 )     (8,795,369 )
    $ 835,963     $ 1,376,582  
                 

Depreciation expense related to property and equipment was $502,748, $562,119, and $718,476, in 2009, 2008, and 2007, respectively.  Depreciation expense for 2009 included $6,063 related to our capital lease obligation for office equipment.

In October 2008, we entered into a firm commitment to sell our ownership percentage in an aircraft.  The net carrying value of this asset was written down to approximately $185,000, representing the quoted selling price of the asset less the estimated costs to sell.   An impairment loss of $30,700 was included in the accompanying statement of cash flows and in general and administrative expenses in the accompanying statement of operations for the year ended December 31, 2008.  We completed the sale of this asset in January 2009 and the proceeds from the sale are included in the accompanying statement of cash flows for the year ended December 31, 2009.

32

 
6.   INTANGIBLE ASSETS

Intangible assets consisted of the following at December 31, 2009 and 2008:

   
2009
 
   
Gross Carrying Amount
   
Accumulated Amortization
   
Net Value
 
Patents and copyrights
  $ 16,109,140     $ 6,351,237     $ 9,757,903  
Prepaid licensing fees
    794,000       473,464       320,536  
    $ 16,903,140     $ 6,824,701     $ 10,078,439  
 
      2008  
   
Gross Carrying Amount
   
Accumulated Amortization
   
Net Value
 
Patents and copyrights
  $ 15,290,771     $ 5,414,668     $ 9,876,103  
Prepaid licensing fees
    1,399,000       876,582       522,418  
    $ 16,689,771     $ 6,291,250     $ 10,398,521  
                         

Periodically, we evaluate the recoverability of our intangible assets and take into account events or circumstances that may warrant revised estimates of useful lives or that may indicate impairment exists (“Triggering Event”).  Based on our cumulative net losses and negative cash flows from operations to date, we assess our working capital needs on an annual basis.  This annual assessment of our working capital is considered to be a Triggering Event for purposes of evaluating the recoverability of our intangible assets.  As a result of our evaluation, and the significant excess of our market capitalization over our net book value at December 31, 2009, we determined that no impairment exists with regard to our intangible assets.

Patent costs represent legal and filing costs incurred to obtain patents and trademarks for product concepts and methodologies that we have developed.  Capitalized patent costs are being amortized over the estimated lives of the related patents, ranging from fifteen to twenty years.  Prepaid licensing fees represent costs incurred to obtain licenses for use of certain technologies in future products.  Prepaid license fees are being amortized over their estimated economic lives, generally two to five years.

Amortization expense for the years ended December 31, 2009, 2008 and 2007 is as follows:

         
Amortization Expense
 
   
Weighted average estimated life
(in years)
   
 
 
2009
   
 
 
2008
   
 
 
2007
 
                         
Patents and copyrights
  17     $ 936,569     $ 886,849     $ 831,788  
Prepaid licensing fees
  2       301,882       171,582       98,750  
   Total amortization
        $ 1,238,451     $ 1,058,431     $ 930,538  
                               
 
Future estimated amortization expenses for other assets that have remaining unamortized amounts as of December 31, 2009 were as follows:

2010
 
$1,237,407
2011
 
966,186
2012
 
916,558
2013
 
888,082
2014
 
865,609
2015 and thereafter
 
5,204,597
 
33

 
7.   INCOME TAXES AND TAX STATUS

A reconciliation between the provision for income taxes and the expected tax benefit using the federal statutory rate of 34% for the years ended December 31, 2009, 2008 and 2007 is as follows:

   
2009
   
2008
   
2007
 
Tax benefit at statutory rate
  $ (7,320,067 )   $ (7,845,125 )   $ (6,192,563 )
State tax benefit
    (753,536 )     (807,586 )     (637,470 )
Increase in valuation allowance
    8,216,530       6,707,907       6,276,369  
Research and development credit
    (375,401 )     1,782,165       118,540  
Other
    232,474       162,639       435,124  
    $ 0     $ 0     $ 0  
                         

Our deferred tax assets and liabilities relate to the following sources and differences between financial accounting and the tax bases of our assets and liabilities at December 31, 2009 and 2008:

   
2009
   
2008
 
Gross deferred tax assets:
           
   Net operating loss carryforward
  $ 73,496,231     $ 68,465,225  
   Research and development credit
    7,041,183       6,739,863  
   Patents and other
    1,466,849       1,285,415  
   Stock compensation
    2,895,368       2,066,316  
   Deferred revenue
    19,025       0  
   Accrued liabilities
    70,854       65,612  
      84,989,510       78,622,431  
      Less valuation allowance
    (84,972,698 )     (78,549,679 )
      16,812       72,752  
Gross deferred tax liabilities:
               
    Fixed assets
    16,812       72,752  
 
    16,812       72,752  
Net deferred tax asset
  $ 0     $ 0  
                 

No current or deferred tax provision or benefit was recorded for 2009, 2008, and 2007 as a result of current losses and full deferred tax valuation allowances for all periods.  We have recorded a valuation allowance to state our deferred tax assets at their estimated net realizable value due to the uncertainty related to realization of these assets through future taxable income.  At December 31, 2009, we had cumulative net operating losses (“NOL”) and research and development (“R&D”) tax credit carry-forwards for income tax purposes of $199,578,661 and $7,041,183 respectively, which expire in varying amounts from 2010 through 2029.  The cumulative NOL carry-forward is net of $3,698,341 in carry-forwards from 1993 and 1994 which expired unused in 2008 and 2009.  Our ability to benefit from the NOL and R&D tax credit carry-forwards could be limited under certain provisions of the Internal Revenue Code if ownership of ParkerVision changes by more than 50%, as defined by Section 382 of the Internal Revenue Code of 1986 (“Section 382”).

Uncertain Tax Positions
We file income tax returns in the U.S. federal jurisdiction and various state jurisdictions.  We have identified our Federal and Florida tax returns as our only major jurisdictions, as defined.  The periods subject to examination for those returns are the 1995 through 2009 tax years. 

During 2008 and 2009, we conducted a study of our NOL and R&D credit carry-forwards since the Company’s formation under Section 382.   Under Section 382, an ownership change may limit the amount of NOL and R&D credit carry-forwards that can be used annually to offset future taxable income and tax, respectively.  In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain shareholders or public groups in the stock of a corporation by more than 50
 
34

 
percentage points over a three-year period.  Based on the results of our study, we have determined that we do not have any ownership changes on or prior to December 31, 2009 which would result in limitations of our NOL and R&D credit carry-forwards under Section 382.

In addition, during 2008, we conducted tax studies related to our R&D tax credits from 1994 to 2007.  Based on our findings, our qualified research expenditures were overstated in prior periods resulting in an adjustment to our cumulative R&D and cumulative NOL tax credit carry-forwards.   The adjustment, aggregating $4,452,021 million, was recognized on our 2008 federal and state tax returns as a reduction in R&D credit carry-forward with a corresponding increase to our cumulative NOL carry-forward.  This adjustment had no impact on our consolidated financial statements.

At December 31, 2009, we had an unrecognized tax benefit of approximately $1.4 million.  A reconciliation of the amount recorded for unrecognized tax benefits for the years ended December 31, 2009, 2008 and 2007 is as follows:

   
For the years ended December 31,
 
 
 
2009
   
2008
   
2007
 
Unrecognized tax benefits – beginning of year
  $ 1,369,614     $ 2,629,296     $ 1,841,995  
  Gross increases – tax positions in prior period
    0       3,192,339       787,301  
  Gross decrease – current period tax positions
    0       0       0  
  Change in Estimate
    0       (4,452,021 )     0  
  Lapse of statute of limitations
    0       0       0  
Unrecognized tax benefits – end of year
  $ 1,369,614     $ 1,369,614     $ 2,629,296  
                         

Future changes in the unrecognized tax benefit will have no impact on the effective tax rate due to the existence of a valuation allowance.   Approximately $0.47 million, net of tax effect, of the unrecognized tax benefit is related to excess tax benefits related to share-based compensation which would be recorded as an adjustment to equity rather than a decrease in retained earnings, if reversed.

Our policy is that we recognize interest and penalties accrued on any unrecognized tax benefits as a component of our income tax expense.  We do not have any accrued interest or penalties associated with any unrecognized tax benefits.  For the years ended December 31, 2009, 2008 and 2007, we did not incur any income tax-related interest income, expense or penalties.   

8.  SHARE-BASED COMPENSATION:

We did not capitalize any expense related to share-based payments.  The following table presents share-based compensation expense included in our consolidated statements of operations for the years ended December 31, 2009, 2008 and 2007, respectively:

   
Year ended December 31,
 
   
2009
   
2008
   
2007
 
Cost of sales
  $ 0     $ 0     $ 20,627  
Research and development expense
    1,967,780       1,695,265       701,042  
Sales and marketing expense
    576,539       543,083       423,675  
General and administrative expense
    2,449,337       2,005,146       1,182,178  
  Total share-based expense   $ 4,993,656     $ 4,243,494     $ 2,327,522  
                       

As of December 31, 2009, there was $4,031,016 of total unrecognized compensation cost, net of estimated forfeitures, related to all non-vested share-based compensation awards.  That cost is expected to be recognized over a weighted-average period of 1.42 years.
 
35

 
Stock Incentive Plans

1993 Stock Plan
We adopted a stock plan in September 1993 (the “1993 Plan”).  As of September 10, 2003, the Company was no longer able to issue grants under the 1993 Plan.  The 1993 Plan, as amended, provided for the grant of options and other stock awards to employees, directors and consultants, not to exceed 3,500,000 shares of common stock.  Options granted to employees and consultants under the 1993 Plan vested for periods up to ten years and were exercisable for a period of five years from the date the options vested. Options granted to directors under the 1993 Plan were exercisable immediately and expire ten years from the date of grant.
  
2000 Performance Equity Plan
We adopted a performance equity plan in July 2000 (the “2000 Plan”). The 2000 Plan provides for the grant of options and other stock awards to employees, directors and consultants, not to exceed 5,000,000 shares of common stock. The plan provides for benefits in the form of incentive stock options, nonqualified stock options, stock appreciation rights, restricted share awards, stock bonuses and various stock benefits or cash.  Awards granted to employees and consultants under the 2000 Plan generally vest over three to five years.  Awards granted to directors under the 2000 Plan are generally exercisable within one year.  Options awarded under the 2000 Plan are generally exercisable for seven to ten years from the grant date.  Forfeited and expired options under the 2000 Plan become available for reissuance.   At December 31, 2009, 283,451 shares of common stock were available for future grants.

2008 Equity Incentive Plan
We adopted a performance equity plan in August 2008 (the “2008 Plan”).  The 2008 Plan provides for the grant of stock-based awards to employees (excluding named executives), directors and consultants, not to exceed 500,000 shares of common stock.  The Plan provides for benefits in the form of incentive stock options, nonqualified stock options, stock appreciation rights, restricted share awards, and other stock based awards.  Forfeited and expired options under the 2008 Plan become available for reissuance.  At December 31, 2009, 312,890 shares of common stock were available for future grants.

Restricted Stock Awards
Restricted stock awards are issued as executive and employee incentive compensation and as payment for services to others.  The value of the award is based on the closing price of our common stock on the date of grant.  Restricted stock awards are generally immediately vested.   During 2009, we granted our employees an aggregate of 17,585 immediately vested shares of restricted stock under the 2008 Plan valued at approximately $57,000.   We had no unvested restricted stock awards at December 31, 2009, 2008, or 2007 and no restricted stock awards were forfeited during 2009.

Restricted Stock Units
In 2008, we implemented a RSU program to supplement our stock option compensation programs.  We have granted RSUs to employees and non-employee directors under the 2000 Plan.  Each RSU represents a right to one share of our common stock, upon vesting.  The RSUs are not entitled to voting rights or dividends, if any, until vested.  A summary of the status of non-vested RSUs as of December 31, 2009, and changes during the year ended December 31, 2009 is presented below:

   
Non-vested Shares
 
   
 
 
Shares
   
Weighted-Average
Grant-Date
Fair Value
 
Non-vested at January 1, 2009
    619,767     $ 10.80  
Granted
    17,500       3.93  
Vested
    (164,207 )     10.68  
Forfeited
    (9,200 )     10.13  
Non-vested at December 31, 2009
    463,860       10.60  
                 
 
36

 
The total fair value of RSUs vested in 2009 is $1,752,963.  The non vested RSUs at December 31, 2009 include 240,000 RSUs awarded to named executives and other officers in 2008 that vest on the earlier of (i) the third anniversary of the grant date or (ii) such earlier date that the price of our common stock achieves certain performance levels as defined in the agreements.  As of December 31, 2009, none of the price performance levels had been achieved and therefore no vesting was accelerated.

The fair value of RSU awards is determined using the closing price of our common stock on the date of grant.  Compensation expense related to RSUs is recognized on a straight-line basis over the requisite service period, net of estimated forfeitures.  For service-based RSUs the requisite service period is the vesting period, generally three years.  For RSUs with market conditions, the requisite service period was determined using a Monte Carlo simulation model.

Stock Options
The following table presents a summary of option activity under the 1993, 2000, and 2008 Plans (collectively, the “Stock Plans”) for the year ended December 31, 2009:

   
 
 
 
Shares
   
Weighted-Average
Exercise
Price
   
Weighted-Average Remaining Contractual Term
   
 
Aggregate Intrinsic
Value ($)
 
Outstanding at beginning of year
    3,726,520     $ 18.61              
Granted
    534,850     $ 3.04              
Exercised
    0       -              
Forfeited
    (401,274 )   $ 39.09              
Expired
    (81,114 )   $ 19.73              
Outstanding at end of year
    3,778,982     $ 14.20       3.46     $ 2,000  
Exercisable at end of year
    3,413,584     $ 15.17       3.19     $ 2,000  
                                 

The aggregate intrinsic value of options exercised under the Stock Plans during 2009, 2008, and 2007 was $0, $717,721, and $806,528, respectively.  The weighted average fair value of option shares granted during the years ended December 31, 2009, 2008 and 2007 was $1.82, $6.98, and $7.55, respectively.  The total fair value of option shares vested during the years ended December 31, 2009, 2008, and 2007 was $2,437,770, $2,761,352, and $2,014,874, respectively.

On May 20, 2009, we granted stock options to purchase an aggregate of 100,000 shares of our common stock at an exercise price of $2.98 per share to an outside consultant under the 2000 Plan as compensation under a consulting agreement.   The options vest in equal monthly increments over the fifteen month term of the agreement and any vested options are exercisable for seven years from the grant date.  Upon thirty days notice, the consulting agreement may be terminated and any unvested options will be cancelled.   The fair value of this option is estimated at each interim reporting date using the Black-Scholes option pricing model.  As of December 31, 2009, an aggregate of 46,669 option shares were vested and the fair value of the option was determined using the Black-Scholes option pricing model with an expected term equal to the remaining contractual life of 6.4 years, volatility of 84.8% and a risk-free interest rate of 3.4%.  Expense related to this option was approximately $108,000 for the year ended December 31, 2009.

The fair value of all other option grants under the Stock Plans for the years ended December 31, 2009, 2008, and 2007 respectively, was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions:
 
37

 
 
Year ended December 31,
 
2009
 
2008
 
2007
Expected option term 1
3 to 5.5 years
 
4 to 7 years
 
4 to 7 years
Expected volatility factor 2
85.0% to 91.1%
 
66.4% to 70.9%
 
65.8% to 74.0%
Risk-free interest rate 3
1.3% to 2.5%
 
1.5% to 3.7%
 
3.6% to 5.0%
Expected annual dividend yield
0%
 
0%
 
0%
           

1
The expected term was determined based on historical activity for grants with similar terms and for similar groups of employees and represents the period of time that options are expected to be outstanding.  For employee options, groups of employees with similar historical exercise behavior are considered separately for valuation purposes.   For directors and named executive officers, the contractual term is used as the expected term based on historical behavior.

2
The stock volatility for each grant is measured using the weighted average of historical daily price changes of our common stock over the most recent period equal to the expected option life of the grant.

3
The risk-free interest rate for periods equal to the expected term of the share option is based on the U.S. Treasury yield curve in effect at the time of the grant.

Non-Plan Options/Warrants

We have granted options and warrants outside the 1993 and 2000 Plans for employment inducements, non-employee consulting services, and for underwriting and other services in connection with securities offerings.  Non-plan options and warrants are generally granted with exercise prices equal to or above fair market value of the underlying shares at the date of grant.

A summary of non-plan option and warrant activity as of December 31, 2009 and changes during the year then ended is presented below:

   
 
 
 
Shares
   
Weighted-Average
Exercise
Price
 
Weighted-Average Remaining Contractual Term
 
 
Aggregate Intrinsic
Value ($)
 
Outstanding at beginning of year
    1,893,819     $ 31.21          
Granted
    481,320       2.02          
Exercised
    (20,000 )     1.88       $ 21,700  
Forfeited
    0       -            
Expired
    (115,000 )     23.15            
Outstanding at end of year
    2,240,139     $ 25.61  
2.02 years
  $ 0  
Exercisable at end of year
    2,215,139     $ 25.86  
1.99 years
  $ 0  
                           
 
On July 1, 2009, we granted stock options to purchase an aggregate of 50,000 shares of our common stock at an exercise price of $3.27 per share to an outside consultant as compensation under a consulting agreement.  These options are for unregistered shares that have “piggy-back” registration rights on subsequent registration statements.  The options vest in equal monthly increments over the twelve month term of the agreement and any vested options are exercisable for five years from the grant date.  Upon ninety days notice, the consulting agreement may be terminated and any unvested options will be cancelled.   The fair value of this option is estimated at each interim reporting date during the option term using the Black-Scholes option pricing model.  As of December 31, 2009, an aggregate of 25,002 option shares were vested and the fair value of the option was determined using the Black-Scholes option pricing model with an expected term equal to the remaining contractual life of 4.5 years, volatility of 85.4% and a risk-free interest rate of 2.7%.  Expense related to this
38

 
option was approximately $46,000 for the year ended December 31, 2009.

In connection with one of the three offerings of shares of our common stock on March 3, 2009, we issued warrants to purchase 431,320 shares of common stock (see Note 9).  These warrants were recorded at their relative fair value of approximately $453,000.

The aggregate intrinsic value of non-plan options and warrants exercised during 2009, 2008, and 2007 was $21,700, $71,488, and $2,805,211, respectively.  Of the non plan warrants and options outstanding at December 31, 2009, warrants representing 2,190,139 shares were issued in connection with the sale of equity securities in various public and private placement transactions in 2000, 2001, 2005, 2006, and 2009.  The estimated fair value of these warrants at the time of issuance of $17,767,663 is included in shareholders’ equity in the consolidated balance sheets.

The options and warrants outstanding at December 31, 2009 under all plans, including the non-plan options and warrants, have exercise price ranges, weighted average contractual lives, and weighted average exercise prices as follows:
 
      Options Outstanding       Options Exercisable  
 
Range of
Exercise
Prices
   
Number Outstanding at December 31, 
2009
   
Wtd. Avg. Exercise Price
   
Wtd. Avg. Remaining Contractual Life
   
Number Exercisable at December 31, 2009
   
Wtd. Avg. Exercise Price
   
Wtd. Avg. Remaining Contractual Life
 
                                       
$ 1.63 - $2.98       521,320     $ 2.08       4.56       467,989     $ 1.98       4.35  
$ 2.99 - $4.66       542,640       3.31       6.02       300,515       3.42       5.83  
$ 4.67 - $7.08       538,960       5.73       3.91       528,960       5.70       3.89  
$ 7.25 - $10.98       1,865,435       8.97       2.65       1,832,218       8.94       2.62  
$ 11.10 - $17.50       264,865       12.46       4.35       213,140       12.58       4.16  
$ 18.94 - $29.96       824,217       23.61       1.48       824,217       23.61       1.48  
$ 31.00 - $48.00       932,209       38.18       1.50       932,209       38.18       1.50  
$ 56.66 - $56.66       529,475       56.66       2.14       529,475       56.66       2.14  
          6,019,121       18.45       2.92       5,628,723       19.38       2.72  
                                                     

Upon exercise of options and warrants under all plans, we issue new registered shares of our common stock.  Cash received from option and warrant exercises under all share-based payment arrangements for the years ended December 31, 2009, 2008, and 2007 was $37,500, $1,349,661, and $6,744,232, respectively.  No tax benefit was realized for the tax deductions from exercise of the share-based payment arrangements for the years ended December 31, 2009, 2008 and 2007 as the benefits were fully offset by a valuation allowance (see Note 7).

9.   STOCK AUTHORIZATION AND ISSUANCE
 
Preferred Stock
ParkerVision has 15,000,000 shares of preferred stock authorized for issuance at the direction of the board of directors.  As of December 31, 2009, we had no outstanding preferred stock.

On November 17, 2005, the board of directors designated 100,000 shares of authorized preferred stock as the Series E Preferred Stock in conjunction with its adoption of a Shareholder Protection Rights Agreement (Note 10).
 
Common Stock and Warrants
We have filed two shelf registration statements with the SEC for purposes of providing flexibility to raise funds from the offering of various securities over a period of three years, subject to market conditions.  
 
39

 
Securities offered under the shelf registration statements may be used to fund working capital, capital expenditures, vendor purchases, and other capital needs.  The first shelf registration statement was filed on January 5, 2009 (File No. 333-156571) and declared effective on January 20, 2009 (“January 2009 Shelf”) for the offering of up to $25 million in securities.  The second shelf registration statement was filed on September 14, 2009 (File No. 333-161903) and was declared effective on September 30, 2009 (“September 2009 Shelf”) for the offering of up to $50 million in securities.
 
On November 10, 2009, we entered into a purchase agreement for the sale of 8,000,000 shares of our common stock at a price of $2.00, par value $0.01 per share, under the September 2009 Shelf.  Piper Jaffray & Co. (“Piper Jaffray”) acted as underwriter for the Company. The Underwriter agreed to purchase the Shares from the Company pursuant to the Purchase Agreement at a discount of $0.14 per share, representing 7.0% of the public offering price, for an aggregate discount of $1,120,000.  The aggregate net proceeds from this offering after underwriter discounts, placement fees and other offering expenses, was approximately $14.6 million which will be used for general working capital purposes.  This offering represented 19.4% of our outstanding common stock on an after-issued basis.
 
On March 3, 2009, we closed three separate but concurrent offerings for the sale of an aggregate of 5,994,963 shares of our common stock and 431,320 warrants under the January 2009 Shelf and received aggregate proceeds, after underwriter discounts, of approximately $9.6 million.   Roth Capital Partners, LLC (“Roth”), acted as underwriter for two of the three transactions.  In addition, on April 1, 2009, we consummated the sale of an additional 250,000 shares from Roth’s exercise of an over-allotment option for additional proceeds, after underwriter discount, of approximately $0.4 million.  The aggregate net proceeds from these offerings, including the over-allotment, after underwriter discounts, placement fees and other offering expenses, was approximately $9.7 million which was used for general working capital purposes.

Pursuant to one underwriting agreement (the “Unit Underwriting Agreement”), we sold 2,156,600 shares of common stock and 431,320 warrants as units, each unit consisting of one share of common stock and two-tenths of a warrant, at an offering price of $1.875 per unit (the “Unit Offering”).  The warrants are exercisable, at an exercise price of $1.875 per share, commencing March 3, 2009 and expire on March 3, 2014.   The underwriter purchased units from us at a discount of $0.15 per unit, representing eight percent (8%) of the public offering price.   The shares of common stock and the warrants comprising the units were issued separately and at all times have traded separately.  Consequently, no “units” were actually issued.   In addition, we granted the underwriter an option to purchase additional shares of common stock and warrants, as units, to cover over-allotments, if any.  The over-allotment option expired unexercised on March 27, 2009.

Pursuant to the second underwriting agreement (the “Stock Underwriting Agreement”), we sold 3,484,309 shares of common stock at a public offering price of $1.665 per share (the “Common Stock Offering”).  The underwriter purchased the common stock at a discount of $0.1332 per share, representing eight percent (8%) of the public offering price.   In addition, we granted the underwriter an option to purchase up to an additional 522,646 shares to cover over-allotments, if any.  On March 27, 2009, the underwriter exercised its over-allotment option and purchased an additional 250,000 shares of Common Stock.  The sale of shares under the over-allotment option was consummated on April 1, 2009.

In connection with the Unit Offering and the Common Stock Offering, we also sold an aggregate of 354,054 shares of our common stock at a price per share of $1.85 to an affiliate of an executive officer and two directors of our company (the “Management Offering”).

The aggregate of the March 2009 offerings, including the over-allotment option exercise, represented 18.9% of our outstanding common stock on an after-issued basis.

On March 5, 2008, we completed the sale of an aggregate of 1,240,199 shares of our common stock to a limited number of domestic institutional and other investors in a private placement transaction pursuant to an offering exemption under the Securities Act of 1933.  Such shares represented 4.7% of our outstanding common stock on an after-issued basis.  1,110,999 shares were sold at a price of $7.50 per share, and 129,200 shares were sold to Mr. Jeffrey Parker, our chief executive officer and chairman, at $7.74 per share.  The net
 
40

 
proceeds of approximately $9 million were used for general working capital purposes.

On February 23, 2007, we completed the sale of an aggregate of 992,441 shares of our common stock to a limited number of domestic   institutional and other investors in a private placement transaction pursuant to offering exemptions under the Securities Act of 1933.  The shares, which represented 4.1% of our outstanding common stock on an after-issued basis, were sold at a price of $8.50 per share, for net proceeds of approximately $8.4 million.  The net proceeds from this transaction were used for general working capital purposes.

10.   SHAREHOLDER PROTECTION RIGHTS AGREEMENT

On November 21, 2005, we adopted a Shareholder Protection Rights Agreement (“Rights Agreement”) which calls for the issuance, on November 29, 2005, as a dividend, rights to acquire fractional shares of Series E Preferred Stock.  We did not assign any value to the dividend as the value of these rights is not believed to be objectively determinable.  The principal objective of the Rights Agreement is to cause someone interested in acquiring us to negotiate with our Board of Directors rather than launch an unsolicited or hostile bid.  The Rights Agreement subjects a potential acquirer to substantial voting and economic dilution.  Each share of Common Stock issued by ParkerVision will include an attached right.

The rights initially are not exercisable and trade with the Common Stock of ParkerVision.  In the future, the rights may become exchangeable for shares of Series E Preferred Stock with various provisions that may discourage a takeover bid.  Additionally, the rights have what are known as “flip-in” and “flip-over” provisions that could make any acquisition of us more costly to the potential acquirer.  The rights may separate from the Common Stock following the acquisition of 15% or more of the outstanding shares of Common Stock by an acquiring person.  Upon separation, the holder of the rights may exercise their right at an exercise price of $45 per right (the “Exercise Price”), subject to adjustment and payable in cash.

Upon payment of the exercise price, the holder of the right will receive from us that number of shares of Common Stock having an aggregate market price equal to twice the Exercise Price, as adjusted.   The Rights Agreement also has a flip over provision allowing the holder to purchase that number of shares of common/voting equity of a successor entity, if we are not the surviving corporation in a business combination, at an aggregate market price equal to twice the Exercise Price.

We have the right to substitute for any of our shares of Common Stock that we are obligated to issue, shares of Series E Preferred Stock at a ratio of one ten-thousandth of a share of Series E Preferred Stock for each share of Common Stock.  The Series E Preferred Stock, if and when issued, will have quarterly cumulative dividend rights payable when and as declared by the board of directors, liquidation, dissolution and winding up preferences, voting rights and will rank junior to other securities of ParkerVision unless otherwise determined by the board of directors.

The rights may be redeemed upon approval of the board of directors at a redemption price of $0.01.  The Rights Agreement expires on November 21, 2015.

11.   COMMITMENTS AND CONTINGENCIES
 
Lease Commitments
We entered into a lease agreement for our headquarters facility in Jacksonville, Florida, pursuant to a non-cancelable lease agreement effective June 1, 2006.  The lease provides for a straight-lined monthly rental payment of $15,806 through October 31, 2011 with an option for renewal.  The lease provides for a tenant improvement allowance of approximately $437,000 which has been recorded in the accompanying balance sheet as leasehold improvements with a corresponding entry to deferred rent.  The leasehold improvements are depreciated over the lease term.  Deferred rent is amortized as a reduction to lease expense over the lease term.
 
We also lease office space in Lake Mary, Florida for our wireless design center.  The lease term, as amended,
 
41

 
was renewed in September 2005 and provides for a straight-lined monthly rental payment of approximately $20,296 through December 2010.
 
In addition to sales tax payable on base rental amounts, certain leases obligate us to pay pro-rated annual operating expenses for the properties.  Rent expense for properties, for the years ended December 31, 2009, 2008, and 2007 was $460,321, $465,820, and $517,188, respectively.

In addition, we lease certain equipment, primarily for research and development activities, under non-cancelable operating leases with lease terms of less than one year.  Equipment rental expense for the years ended December 31, 2009, 2008 and 2007 was $234,627, $211,112, and $220,169, respectively.

Future minimum lease payments under all non-cancelable operating leases and capital leases that have initial or remaining terms in excess of one year as of December 31, 2009 were as follows:

Contractual Obligations:
 
2010
   
2011
   
Total
 
   Capital leases
  $ 23,000     $ 37,000     $ 60,000  
  Operating leases
    582,000       251,000       833,000  

On January 1, 2007, we adopted the provisions for the accounting for uncertainty in income taxes.  The total amount of gross unrecognized tax benefits for uncertain tax positions at December 31, 2009 was $1,369,614.  Payment of these obligations would result from settlements with taxing authorities.  Due to the difficulty in determining the timing of settlements, these obligations are not included in the table above.

Legal Proceedings
We are subject to legal proceedings and claims which arise in the ordinary course of our business.  We believe, based upon advice from outside legal counsel, that the final disposition of such matters will not have a material adverse effect on our financial position, results of operations or liquidity.    

12.   RELATED-PARTY TRANSACTIONS
 
On November 16, 2009, the Parker Trust, a trust for the benefit of the dependents of Jeffrey Parker, our chairman and chief executive officer, purchased 50,000 shares of our common stock in an offering underwritten by Piper Jaffray.  In addition, Stacie Wilf, sister to Jeffrey Parker, purchased 155,000 shares in the same offering.   The shares were purchased at the offering price of $2.00 per share.

On March 3, 2009, we sold 354,054 shares of our common stock at a price per share of $1.85 in a Management Offering.  The Parker Trust purchased 270,272 shares of our common stock and Robert Sterne and Papken der Torossian, each a director of ours, purchased 2,701 and 81,081 shares of our common stock, respectively.
 
On March 5, 2008, we sold 129,200 shares of our common stock in a private placement transaction to our chief executive officer, Jeffrey Parker at a price of $7.74 per share.

We paid approximately $909,000, $1,160,000, and $1,129,000 in 2009, 2008, and 2007, respectively, for patent-related legal services to a law firm, of which Robert Sterne, one of our directors since September 2006, is a partner.

13.   CONCENTRATIONS OF CREDIT RISK

Financial instruments that potentially subject us to a concentration of credit risk principally consist of cash and cash equivalents.  At December 31, 2009, we had cash balances on deposit with banks that exceeded the balance insured by the F.D.I.C.  We maintain our cash investments with what management believes to be quality financial institutions and limit the amount of credit exposure to any one institution.
 
42


14.   FAIR VALUE MEASUREMENTS
 
On January 1, 2008, we adopted the FASB guidance that defines fair value, establishes a framework for measuring fair value and establishes a fair value hierarchy that prioritizes the inputs used to measure fair value.  The standard describes three levels of inputs that may be used to measure fair value: (i) Level 1: Quoted prices in active markets for identical or similar assets and liabilities; (ii) Level 2: Quoted prices for identical or similar assets and liabilities in markets that are not active or observable inputs other than quoted prices in active markets for identical or similar assets and liabilities, and (iii) Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

We have determined the estimated fair value amounts of our financial instruments using available market information.  Our financial assets and liabilities are limited to money market securities.  The value of those money market securities at December 31, 2009 and 2008 is included in the following:

     
Fair Value Measurements Using
 
   
 
Money market securities value at
   
 
Quoted prices in Active Markets (Level 1)
   
Significant Other Observable Inputs
(Level 2)
   
Significant Unobservable Inputs
(Level 3)
 
December 31, 2009
  $ 11,402,000     $ 11,402,000       -       -  
December 31, 2008
    4,584,000       4,584,000       -       -  
                                 

15.   QUARTERLY FINANCIAL DATA (UNAUDITED)

The quarterly financial data presented below is in thousands except for per share data:

   
For the three months ended
   
For the year ended
 
   
March 31,
2009
   
June 30,
2009
   
September 30, 2009
   
December 31, 2009
   
December 31,
2009
 
                               
Revenues
  $ 0     $ 0     $ 0     $ 64     $ 64  
Gross margin
    0       0       0       10       10  
Net loss
    (5,142 )     (5,757 )